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Abstract 
There is no cure for the fatal progression of Amyotrophic Lateral Sclerosis (ALS). 
Optimization of quality of life is the primary ALS treatment goal (Simmons, 2005). 
Consolidating multiple appointments into one visit is advantageous due to the severity of 
muscular deterioration and mobility problems associated with the disease. 
Multidisciplinary Clinics (MDC) provide improved care coordination, accessibility to 
health care professionals skilled in treating ALS, and improvements in symptom control 
for patients with ALS.  
The purpose of this study is to discuss the differences in quality of life, physical 
health status, and coping skills for individuals with ALS attending multidisciplinary 
clinics versus those receiving traditional, practitioner driven care. The investigation is 
part of a larger program of research designed to identify and address the psychosocial 
needs of individuals with ALS.  The literature is void regarding factors connected to the 
reasons why individuals choose to attend an MDC, compared with receiving traditional 
practitioner driven care. Grounded theory was utilized to analyze and compare data by 
coding categories related to patient choice to utilize a multidisciplinary clinic or to utilize 
traditional care. This approach is specifically designed to provide supporting evidence 
that multidisciplinary clinics optimize quality of life for patients with ALS. This study 
was conducted through an online survey; 403 people initiated the survey, and 329 met 
inclusion criteria. Individuals who attend ALS clinics perceive Quality Of Life (QOL) as 
being higher in physical function and bulbar function, although those patients have lower 
levels of physical function, as measured by the ALSFRS-R. Thus, individuals attending a 
MDC differ in this survey from those who do not attend. 
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Chapter 1 
Statement of the Problem and Purpose of the Study 
Amyotrophic lateral sclerosis (ALS), characterized by paralysis and death within 
three to five years of diagnosis, is a neurodegenerative disease for which there is no cure 
(Simmons, 2005). Symptomatic treatments are important in controlling major 
consequences of ALS; these include pain, sleep disorders, spasticity, emotional liability, 
and depression (Simmons, 2005). Multidisciplinary clinics (MDC) cater exclusively to 
patients with ALS to provide coordinated treatment and formulate interventions to 
improve quality of life (Zoccolella et al., 2007). 
Multidisciplinary clinics offer a coordinated approach to care, utilizing specialty 
teams of neurology, nursing, physical therapy, occupational therapy, speech therapy, 
pulmonology, nutrition, psychology, social work, respiratory therapy, and representatives 
from ALS associations. Clinic staff works with outside health care professionals, home 
health care aides, and hospice caregivers to provide complete care. Consolidating 
multiple appointments into one visit is advantageous for ALS patients due to mobility 
problems associated with the disease and also for maximal interdisciplinary 
collaboration. 
There is no cure for the fatal progression of ALS. Primary treatment goals for 
patients with ALS must include optimization of quality of life. Multidisciplinary clinics 
provide improved care coordination, accessibility to health care professionals skilled in 
treating ALS, and improvement in symptom control. These clinics also benefit caregivers 
of ALS patients by providing support and encouragement. 
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Individuals with ALS may choose to attend a MDC for personal reasons, health 
care beliefs, or other factors.  ALS patients may perceive the fact that the MDC provides 
not only access to physicians specially trained in ALS, but also access to research and 
new treatments. Traynor (2003) found a significant increase in survival rates for ALS 
patients who attended a MDC. The prospective population-based study found that 
patients enrolled in a multidisciplinary ALS clinic cohort had a mean increase survival of 
7.5 months longer than patients who used the general neurology clinic. The results 
suggest the multidisciplinary approach to care is associated with improved survival rates.  
In a sample study designed to evaluate patient quality of life, Van den Berg 
(2005) found multidisciplinary clinics improve social functioning and mental health. The 
study sampled 208 patients with ALS; 133 patients attended a multidisciplinary clinic and 
75 patients received general ALS care. The percentage of individuals who received 
adequate aids and appliances was higher in patients receiving care from a 
multidisciplinary clinic, compared with patients receiving general care. The results 
indicate patient quality of life is improved in multidisciplinary clinics as a result of 
increased access to services and referrals.  
Current research does not document the reasons why individuals choose 
multidisciplinary clinics over other traditional practitioner driven care. Expert opinion in 
the field and research suggests that attending a MDC improves care, survival rates, and 
QOL: The reality is that many individuals choose not to receive care in these settings, and 
the research is void in describing the factors that contribute to ALS patients’ utilization of 
MDC. Information from ALS patients is valuable in determining the factors that 
influence individual patient choice to utilize MDC. In a broader context, the information 
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validates the establishment of amyotrophic lateral sclerosis multidisciplinary clinics, and 
generalizes the clinic approach to other areas of the medical field. The focus of the 
current qualitative study is to understand the reasons why patients utilize the 
multidisciplinary clinic approach, the perceived benefits from this system of care, and to 
identify barriers for those who do not attend. In addition to qualitative descriptions, a 
series of responses from qualitative questions are analyzed to identify psychological, 
social, and support needs of ALS patients. Analyses may include recommendations for 
medical practitioners regarding provision of care or resources to improve quality of life, 
to decrease depression and anxiety, and to improve the current MDC approach.   
The investigation is part of a larger program of ALS research designed to identify 
and address the psychosocial needs of individuals with ALS, their caregivers, and 
families. In 2008 the Penn State Milton S. Hershey Medical Center conducted a 
population-based study of the quality of life of individuals diagnosed with ALS. The 
study was designed to compare the QOL, differences in states of health of individuals 
who attended MDC with those who did not. The study was on-line, but a paper copy 
questionnaire was also available. Participants provided demographic information, 
completed the ALS Functional Rating Scale Revised, and the ALS Specific Quality of 
Life Revised measure. Four hundred and twenty-five individuals responded to the survey, 
384 in USA, and 41 worldwide; 68% attended ALS clinic and 32% did not. A primary 
outcome was that there were no significant differences in the QOL reports by individuals 
with ALS who attend MDC, compared with those who do not attend a clinic. Future 
directions from that study were to evaluate the impact that a MDC has on patient QOL, 
and the reasons why patients attend an MDC versus stand alone care for their treatment. 
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A qualitative research approach was suggested in order to inquire about the reasons why 
individuals attend or do not attend a MDC through an open ended question.  
This study is designed to answer questions raised from the original research 
completed at Penn State Milton S. Hershey Medical Center to understand the reasons 
why people choose different forms of care. The previous study at Penn State Milton S. 
Hershey Medical Center identified the fact that patients who attended a MDC were more 
likely to use supportive care of non invasive ventilator support, power wheel chairs, be 
administered oral Riluzole, and participate in experimental trials. The non-clinic patients 
receiving palliative care in the sample were more likely to receive no treatment and have 
a tracheotomy performed. The two groups were significantly different in medical 
interventions.  
This study intends to understand the differences between groups. Collecting 
qualitative data will allow the researcher to perform comparisons between and within 
groups to identify each incident for similarities and differences for themes of acceptance 
of the disease, and other salient factors that individuals use to determine medical need, 
and maintain and improve QOL. The source of QOL may not be the medical 
interventions received at the MDC; it may rather involve some personality trait associated 
with acceptance and problem solving of the individual. This qualitative approach allows 
the researcher to differentiate one theme from another, and identify specific properties of 
a theme. The use of comparisons provides a meaning of events that might otherwise seem 
obscure, and discover variations as well as general patterns to generate new knowledge 
(Corbin & Strauss, 2008).  
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Chapter 2 
Literature Review 
Etiology of Amyotrophic Lateral Sclerosis 
 Amyotrophic lateral sclerosis is a neurodegenerative disease affecting motor 
neurons, characterized by paralysis and death within three to five years from time of 
diagnosis (Simmons, 2005; National Institute for Neurological Disorders and Stroke, 
(NINDS). There is no effective cure for ALS, the most common motor neuron disease, 
which is progressive and invariably fatal (Rocha, 2005). ALS, which targets nerve cells, 
is responsible for voluntary muscles (Rocha, 2005), and is hallmarked by gradual decline 
in function of all muscles under voluntary control and loss of ability to move arms, legs 
and body (NINDS). The onset of ALS is characterized by subtle symptoms frequently 
overlooked and includes twitching, cramping, stiffness of muscles, muscle weakness 
affecting an arm or a leg slurred speech and difficulty chewing or swallowing. The 
sequence of emerging symptoms and rate of disease progression varies; eventually 
patients can not ambulate and report loss in the use of extremities. Individuals develop 
difficulty swallowing and chewing, thus impairing their ability to eat normally, causing 
weight loss. ALS patients may die as a result of respiratory failure when the muscles in 
the diaphragm and chest wall fail, causing an inability to breathe without ventilator 
support (NINDS). 
Prevalence rates. Annual incidence of ALS is 1 to 2 per 100,000 population and 
the prevalence is 6 per 100,000 (Rocha, 2005). A significant amount of ALS cases are 
sporadic; and five to ten percent are familial. ALS occurs in adults, with the highest 
frequency of onset between 40 and 60 years of age (NINDS). Male to female ratio is 
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1.5:1, and reaches unity at age 70 (Rocha, 2005). Statistics show that 20,000 Americans 
have ALS, and an estimated 5,000 people in the United States are diagnosed with the 
disease each year (Corcia & Meininger, 2008; Mitchel, & Borasio, 2007). ALS is a 
prevalent neuromuscular diseases worldwide, and people of all races and ethnic 
backgrounds are affected (Corcia & Meininger, 2008; NINDS). ALS occurs apparently at 
random with no associated risk factors in 90-95 percent cases (Corcia & Meininger, 
2008; NINDS). Patients do not have a family history of the disease, and their family 
members are not considered to be at increased risk for developing ALS. 
Treatment. Riluzole is the only medication that the Food and Drug 
Administration (FDA) has approved for the treatment of ALS (Simmons, 2005; 
Radunociv, Mitsumoto & Leigh, 2007). Riluzole, which is believed to reduce damage to 
motor neurons by decreasing the release of glutamate, (Simmons, 2005) does not reverse 
the damage already done to motor neurons. Clinical trials with ALS patients show that 
Rilozole prolongs survival by several months, and prolongs time prior to patient need for 
ventilation support (Radunociv et. al. 2007).  
End of life issues. ALS is a progressive and terminal disease, and patients will 
experience inadequate nutrition, respiratory insufficiency, increasing discomfort, and 
psychological distress (Averill, Kasarskis & Segerstrom, 2007). Providing ALS patients 
comfort and a peaceful death is a primary goal during the terminal phase. End of life care 
is provided in various settings, dependent upon patient preferences, skills, abilities, and 
caregiver choice (Shoesmith & Strong, 2006). Individuals may choose to reside in 
hospital settings, hospice, or die at home. Shoesmith and Strong (2006) state that 50 
percent of individuals die at home, with hospice support, as a result of respiratory failure. 
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Palliative care interventions can alleviate air hunger by providing oxygen; can provide 
anxiety treatment with benzodiazepines, and provide nausea treatment with antiemetics  
(Shoesmith & Strong, 2006).  
Albert and colleagues, (2005) examined the wish to die in a prospective study of 
ALS patients. Participants with advanced ALS had a likelihood of death within six 
months. Patients and care givers were interviewed monthly with a psychosocial 
assessment and depression screening tool. Eighty participants were enrolled in the study; 
 53 died during the course of the investigation; ten expressed a wish to die, and three 
hastened their deaths (Averill, Kasarskis, & Segerstrom 2007). Individuals expressing a 
wish to die met diagnostic criteria for depression; however, differences were less when 
questions regarding suicide were excluded from the depression screening tool. Patients 
indicating a wish to die verbalized less optimism, less religiosity, and greater 
hopelessness. The author suggests that the wish to die is not linked solely to depression, 
and is a broader syndrome of “end of life despair” described by McDonald et al. (1994), 
which include suffering, loss of interest, absence of pleasure, and pessimism. Individuals 
hastening death reported increased control ratings and ratings of suffering decreased in 
the final weeks of life. Albert et al. (2005) concludes that gaining control over dying 
brought mental health benefits and an element of control over ALS.  
Albert et al. (2005) found that patients expressing the wish to die were less likely 
to use nasal ventilation, and patients hastening death did not use nasal ventilation. Greater 
than 50% of the individuals who did not express a wish to die utilized the device.  
Ventilation devices do not substantially extend survival in ALS patients, yet use of 
ventilators may indicate a patient’s interest in living.  
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Averill et al. (2007) discusses a continuum in which resilience and ability to find 
meaning in life are at one end, and psychological distress, hopelessness and pessimism 
are at the other end of the continuum, based on specific patient personalities, coping 
mechanisms, and protective factors; these include: social support, socioeconomic status, 
and history of depression or other mental health disorders. At the time of diagnosis 
premorbid conditions are magnified, suggesting that health care practitioners need to 
evaluate patient mental health status prior to an ALS diagnoses to determine, accurately, 
mental health needs, and provide appropriate interventions impacting QOL. 
Depression.  ALS does not typically impair mind or intelligence; however, 
several studies suggest that ALS patients may have alterations in cognitive functions of 
decision making and memory (Simmons, 2005). Awareness of progressive loss of 
function leads to anxiety and depression, and lower quality of life (NINDS; Kurt, 
Nijboer, Matuz, & Kubler, 2007). Kurt and colleagues (2007) found the prevalence rates 
for depression in ALS patients ranging from 0% to 44%. Reported prevalence rates of 
depression vary, leading researchers to question the traditional depression screening tools 
used to diagnose depression in ALS patients (Kurt et al. 2007; Simmons, 2005). 
Diagnosing of depression is complicated because somatic complaints of loss of appetite, 
weight loss, psychomotor retardation, insomnia, and hypersomnia are symptoms resulting 
from ALS, but also mimic signs of depression. Averill et al. (2007) conclude that clinical 
depression may not be as prevalent for vulnerable populations as initially suspected by 
health care practitioners, although patients with depression and anxiety have lower 
quality of life, psychological distress, and lower satisfaction with life. (Vignola et al. 
2008).  
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Multidisciplinary Clinics 
 Progression of ALS cannot be cured or stopped. The primary treatment goal for 
patients with ALS is the optimization of quality of life. Multidisciplinary clinics provide 
an interdisciplinary approach to care in order to promote the highest quality of life. A 
multidisciplinary clinic has the availability of different professionals and perspectives, 
providing improved care coordination and easing accessibility for patients, thought to 
lead to an improvement in symptom control and improved quality of life. 
Multidisciplinary clinics are hypothesized to benefit caregivers and are encouraged for 
ALS patients in order to experience improved quality of life. 
Cancer multidisciplinary clinics.  Current and emerging research supports the 
efficacy and use of MDC across a wide range of medical specialties. Ducharme and 
Colleagues (2005) found usual care, compared with a MDC specializing in congestive 
heart failure, reduced the number of hospital readmissions and hospital days, and 
improved patients’ quality of life. Ducharme et al. (2005) randomly assigned 230 patients 
to standard care and an MDC specializing in heart failure. The MDC group of patients 
received access to cardiologists and allied health professionals, and at the end of a six 
month period, fewer patients in the intervention group required readmission (Ducharme 
et al., 2005). Both groups were given the Minnesota Living with Heart Failure 
questionnaire. The interventions group had substantial improvement in emotional and 
physical quality of life scores, compared with the control group (Ducharme et al. 2005). 
 Gabel and colleagues (1997) found that MDC for breast cancer increased patient 
satisfaction by including family members and friends in the decision making process, and 
decreased the amount of time from diagnoses to treatment. Anonymous questionnaires 
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were used to evaluate patient satisfaction of 177 patients in the intervention group who 
received care in a MDC setting, compared with 162 patients in a control group who were 
evaluated and treated at a hospital (Gabel, Hilton, & Nathanson, 1997). A retrospective 
chart review was completed on both groups to determine the amount of time between 
diagnoses and treatment. The study found increased patient satisfaction for individuals 
enrolled in a MDC, compared with the control group who were receiving traditional care, 
supporting the conclusion that MDC improve patient QOL.  
ALS Multidisciplinary Clinics.  A single study conducted in Southern Italy 
found that a multidisciplinary approach to care did not improve ALS survival rates 
(Zoccolella et al., 2005). Of 126 patients registered over a two year period, 84 were seen 
in a multidisciplinary clinic and 42 in general neurology clinics. There were no 
significant differences in onset, age, sex distribution, or interventions between the two 
groups, although more people attending multidisciplinary clinic received Riluzole. The 
median survival times from symptom onset were 26 months versus 32.3 or diagnosis 17.6 
months versus 18 (Zoccolella et al., 2005). The results were not significantly different, 
and analyzing those with bulbar onset independently made no difference (Zoccolella et 
al., 2005). 
 Traynor and colleagues (2003) studied 345 Irish residents diagnosed with 
suspected to definite ALS from January 1996 to December 2000. Traynor found 24 
percent of the patients used the multidisciplinary ALS clinic, and the remaining patients 
accessed general neurology clinics. The prospective population-based study showed that 
patients enrolled in a multidisciplinary ALS clinic cohort had a mean increase survival of 
7.5 months longer than for patients using general neurology clinics (Traynor et al. 2003). 
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The multidisciplinary cohort received Riluzole and had more improved prognoses than 
patients attending a general neurology clinic. Results suggest the multidisciplinary 
approach to care is associated with improved survival rate. Patients with bulbar onset 
disease benefited form the aggressive management received in clinic type settings.   
 Van den Berg and colleagues (2005) found that multidisciplinary approaches to 
patient care improve quality of life, result, prominently in social functioning and mental 
health. The study sampled 208 patients with ALS; 133 patients attended a 
multidisciplinary clinic and 75 received general ALS care. No differences were found on 
the physical functioning scale; however, the percentage of patients who received 
adequate aids and appliance, compared with those patients not involved in an ALS clinic, 
was higher in patients in a multidisciplinary clinic. Results indicate patient quality of life 
is improved in multidisciplinary clinics as a result of increased access to services and 
referrals, and higher standard of care. 
Local clinical scientist.  Stricker (2006) defines the Local Clinical Scientist 
(LCS) model as a view of each clinical interaction as a research project; clinicians 
observe the effects, learn from observation and data, and apply learning to the next 
patient or research project. The treatment of individuals with ALS is complex, and 
requires the management of medical problems, mental health and social issues and 
multifaceted disabilities. As a result, the multidisciplinary approach to care has become 
more preferable. The goals of MDCs are to provide optimal care and basic research about 
ALS (Simmons, 2005).  
Expert opinion considers the clinic approach as improving quality of life. Themes 
concerning reasons why individuals use this approach over traditional care provided by a 
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community physician are unknown. A local clinical scientist model allows the clinician 
working with an ALS patient at a multidisciplinary clinic to understand the salient factors 
that underlie the reasons why many use the clinic for care, and how this approach 
improves quality of life. LCS models provide the framework to inquire when the unique 
problem has no clear answers provided by current research.  LCS models seek 
affirmation or contradictory evidence to the research question, and responds to the needs 
of the community (Stricker, 2006). Clinicians review each response from the patient as a 
research project and makes clinical changes when supporting evidence is obtained 
(Stricker, 2006).  
Research on the reasons why ALS patients utilize a multidisciplinary clinic is 
limited, and leads the practitioner to question how this approach is better than treatment 
in other systems. Understanding benefits of a multidisciplinary clinic provides valuable 
information about the reasons why people use multidisciplinary care, and may be 
generalized to other disease models currently using this model, or considering the use of 
this delivery system. Practitioners in local settings are charged with combining 
observations and existing research to develop effective approaches (Stricker & 
Trierweiler, 2006). Flexibility provides community members with the ability to generate 
research questions and collaborate with researchers. Collection and analysis of data are 
carried out jointly, and the ALS community drives how knowledge will be used and new 
practices implemented. 
Current research has not provided a clear understanding about the reasons why 
ALS patients utilize MDCs, leading local clinical scientists to attempt to understand the 
variance in data and explore this question. The qualitative method helps to bridge the gap 
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in quantitative research, and provides the medical community evidence-based practices. 
The information is valuable in determining how individuals select medical services and in 
a broader context validates the establishment of ALS clinics, and generalizes the 
approach to other areas of the medical field. A local clinical scientist model guides new 
provision of care and utilization of resources to improve quality of life.  
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Chapter 3 
Hypothesis and Research Question 
 This research project was guided by the question of the reasons why ALS patients 
attend or do not attend a MDC, reasons for continued attendance, and what factors would 
influence attending a MDC. It was hypothesized that the reasons why an individual seeks 
care at a multidisciplinary clinic is to improve or influence patient quality of life through 
additional services and resources, durable medical equipment, access to mental health 
services, and access to clinical trials at a much higher rate. The study examined through 
open ended questions, the characteristics of individuals who do, or do not access care at 
multidisciplinary clinics, and explored what additional services, referrals, and treatments 
are offered. Individuals accessing MDC may have different coping styles that influence 
how they choose to receive care. Information from individuals affected by ALS would 
supply valuable data to practitioners, guide future interventions, and supply a new facet 
of quality of life to the clinical community. Based on these variables, the following were 
the proposed study hypotheses. 
Hypotheses (H)  
H1: Participants who attend an ALS MDC will have better problem solving skills than 
individuals who do not attend, based on Social Problem Solving Inventory-R. 
H2: Participants who attend an ALS MDC will have overall better QOL than individuals 
who do not attend 
H3: Participants who attend an ALS clinic will have higher levels of physical function 
than individuals who do not attend. 
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H4: Participants who attend a MDC will receive more treatments and services for 
maintaining QOL, compared with non-attendees. 
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Chapter 4 
Methodology 
Overview 
 This study utilized a mixed method of qualitative and quantitative approaches to 
study the differences between individuals diagnosed with ALS who access MDC and 
those who do not. Precise focus was on perceived QOL, functional rating, and social 
problem solving coping skills. Previous research has shown no difference between 
attendees and non-attendees with regard to QOL and physical functioning (Stephens, 
Walsh, & Simmons, 2008) Social problem solving skills have been shown to affect 
negative emotion of ALS patients and predict QOL in ALS caregivers (Murphy, Felgoise, 
Walsh, & Simmons, 2009). This study replicated the previous study, with the addition of 
evaluating social problem solving to determine if rational and systematic approach to 
problem-solving and decision-making may affect the personal choice of health care 
delivery or differentiate between those with higher and lower quality of life. Qualitative 
information was obtained to understand and explore the reasons why people choose to 
attend or not attend a MDC. 
Qualitative information was obtained from participants who completed a series of 
open ended questions designed to solicit information regarding MDC utilization: 1) Why 
do you go to a MDC?, 2) What are the advantages and disadvantages of receiving care 
from a MDC?, 3) If you do not go to a MDC, please tell us the reasons why you do not, 
and 4) What are the circumstances in which a person not attending a clinic would 
consider receiving care at this type of center? The participants were asked objective 
questions concerning those who influenced their decisions to attend a clinic, how they 
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became aware of these services, what was their traveling distance to the clinic, and what 
additional services, referrals, and treatments were offered by attending an ALS clinic. 
Participants provided standard demographic information, including: 1) age, 2) gender, 3) 
ALS symptom onset, 4) site of ALS symptom onset, 5) date of ALS diagnoses, and 6) 
state, zip code, and country.  
The study was conducted in the form of an on-line internet survey. The web based 
survey hosted on the internet utilized the survey software, “Survey Monkey”. Control 
over who accessed the survey and the number of people completing the survey was 
limited. Penn State Milton S. Hershey Medical Center hosted the survey, and after 
completion of the survey, participants’ web browser was returned to the homepage of the 
Penn State MSHMC ALS Clinic (http://www.alsphiladelphia .org/pennstatehershey/). 
Design and Design Justification 
 Not all patients with ALS receive medical treatments from a MDC, opting to be 
treated by neurologists and health care practitioners outside of the MDC system. This 
study was designed to understand and explore various aspects of human experience in 
determining health care decisions. A mixed method approach of quantitative and 
qualitative research provides openness to new and unexpected discoveries emerging from 
the data, openness to the unexpected, coupled with a willingness to redirect innovative 
research as new insights emerge.  The approach was intended to provide narrative 
accounts and interpretations, and sought to better understand how individuals make 
health care decisions, thus providing health care practitioners with valuable information 
in determining treatment options, and conceivably enhancing QOL. Quantitative 
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components of the study sought to identify potential differences between attendees and 
non-attendees’ QOL, physical function, and social problem-solving coping skills.  
Design and Design Justification 
This was a mixed method study with qualitative and quantitative components. 
Study participants were surveyed, using a series of open ended questions designed to 
solicit information about the reasons why ALS patients attend a MDC, frequency of 
attendance, reasons for continued treatment at a multidisciplinary clinic, and under what 
circumstances a person not attending a clinic would consider receiving care at this type of 
center. Participants were asked objective questions concerning those who influenced their 
decisions to attend a clinic, those who provided knowledge of these services, how far 
they traveled to the clinic, and what additional services, referrals, and treatments were 
offered by attending an ALS clinic.  
Group assignment. Question number one, How often have you attended a 
multidisciplinary clinic (MDC) provides six possible responses: 1) Never, and I have no 
plans to attend a MDC; 2) Never, but I have a scheduled appointment or plan to attend in 
the upcoming future; 3) One time for a single diagnostic visit, but I have no plans to 
attend again; 4) One time, and I have a scheduled appointment or plan to attend in the 
upcoming future; 5) More than 1 time, and I plan to continue my treatment at a MDC; 6) 
More than 1 time, and I do not plan to continue my treatment at a MDC.  Participants 
were allowed to check only one box. Checking box numbers 1, 3, and 6 placed the 
respondent in the non-attendee group, and box number 2, 4, and 5 placed the participant 
in the attendee group.  
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Quantitative design.  The quantitative component of the study asked participants 
to complete the ALS Specific Quality of Life Questionnaire (ALSSQOL-R), the ALS 
Functional Rating Scale Revised (ALSFRS-R), and a coping measure titled the Social 
Problem Solving Inventory Revised Short version. (SPSI-R: S). Participants were asked 
to provide demographic information of age, gender, onset, diagnosis information, 
country, state, and zip code. The study was conducted in the form of an anonymous, on-
line, web based internet survey.  
Sources of distress for people diagnosed with ALS include anticipation of 
suffering, treatment regimens, difficulty coping with life changes, and adjusting to 
inherent uncertainty and uncontrollability of the illness. Patients with ALS suffer from 
moderate to severe psychological distress and face substantial difficulties in coping with 
the illness. Differences in problem solving contribute to how patients perceive and 
control ALS, to feelings of hopelessness, and the ability to resolve day in and day out 
problems; all of these are impacted by individual ability to solve stressful problems.  
Social problem solving is defined by D’Zurilla & Maydeu-Olivares (1995) as a 
self-directed, cognitive behavioral process in which a person identifies adaptive ways to 
address stressful everyday life situations. Ineffective problem-solving has been shown to 
be a significant mediator of stressful life experiences, and contributes to how people view 
the world and individual circumstances (D’Zurilla & Maydeu-Olivares, 1995) Individuals 
with ALS who are unable to problem solve effectively may be vulnerable to feelings of 
hopelessness, decreased ability to cope, and decreasing QOL.  
Qualitative design.  A qualitative research approach was chosen in order to 
understand and examine reasons, beliefs, and perceptions of ALS patients who utilize an 
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ALS multidisciplinary clinic, and to measure quality of life through quantitative analysis. 
The goal of the qualitative component was to describe and interpret the unique human 
experiences of patients who access a multidisciplinary clinic, understand individual 
interpretations of health care delivery, identify perceived benefits, and determine the type 
of treatment sought. Participants were asked open ended question to gather data about 
attitudes, perspectives, behaviors, and personality. This approach is useful when the 
researcher needs to know how individuals understand themselves, and the world.   
The quantitative approach was chosen to evaluate study participants of the clinic 
and non clinic population in demographics, quality of life, problem-solving abilities, and 
health status, and evaluate descriptive differences between the two populations. 
Administration of standardized measures rather than qualitative questions enabled the 
researchers to measure differences in the population who attend or do not attend 
multidisciplinary ALS clinics.  
 In order to determine reasons why ALS patients utilize multidisciplinary clinics, 
this study incorporates individuals who access multidisciplinary clinics, and those who 
receive care from practitioners outside of the system. The investigator’s hypothesized 
theme for the reasons why ALS patients utilize the multidisciplinary approach was 
identified through a qualitative analyses based on grounded theory by Corbin & Strauss, 
(2008), and standards for coding qualitative data in the field. 
The qualitative research approach is designed to gain knowledge and 
understanding of under explored aspects of human experience, focusing on individual 
narrative accounts, interpretation, and contextual meanings (Corbin & Strauss, 2008). 
Grounded theory is defined as a methodology of analysis linked with data collection that 
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uses a systematically applied set of methods to generate a theory (Corbin & Strauss, 
2008). This approach recognizes the importance of developing an understanding of an 
experience, phenomenon or process that is contextual grounded by individual knowledge 
and life experiences. Developing increased theoretical knowledge of patient experience is 
valuable in constructing theory and understanding about what is occurring within a 
situation by exploring phenomena, gathering data related to research questions, allowing 
theory to emerge from data; this the process gradually builds a holistic picture of what is 
being explored. Narratives from the participants are analyzed until participant themes are 
understood.  
Participants 
Participants were recruited through advertisements distributed by the ALS 
Association, Patientslikeme.com, and ALS Centers of Excellence. The ALS Association 
is a national organization with affiliate networks comprising both chapters and free 
standing support groups throughout the United States. Local chapters are multifaceted 
organizations responsible for carrying out the mission of the greater ALS National 
Association, and provide a variety of patient care initiatives. ALS support groups are 
collections of individuals that meet regularly for the purpose of providing mutual support 
and information to ALS patients, care givers, and families. ALS Association Chapters 
support patient services, community services, public awareness, advocacy, and research. 
A Research flyer and letter announcing the research project was sent to the National ALS 
Association. National and state chapters distributed information to registered ALS 
patients, and posted the study announcement in newsletters. Local chapters and center 
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directors notified ALS patients who utilize support groups and were registered with the 
chapters.  
Patientslikeme.com is a web site for individuals to share information that can 
improve the lives of people diagnosed with ALS. Patientslikeme.com collects patient 
data, and provides data sharing partnerships with physicians, research organizations, and 
non profits. Patientslikeme.com advertised the study via a national web site.  
The ALS Association certifies and supports regional institutions recognized as 
having experience and knowledge with ALS. Penn State Milton S. Hershey Medical 
Center is a Center of Excellence, and hosted this web based survey on the internet, using 
Survey Monkey software. Written notification of the study provided participants with 
detailed information regarding the research objectives, directions in how to access the 
survey through the URL of the research study internet site, and a point of contact for the 
study coordinator about questions or concerns regarding the study.  
Individuals who identified as having been diagnosed by a health care professional 
with ALS or MND, including upper motor neuron and lower motor neuron disease were 
eligible to participate. The study drew ALS patients from across the United States, 
including individuals attending ALS MDC, and those receiving care from outside the 
MDC system. Ten participants self-identified residence outside of the United States and 
were included in the study. Participants were male and female, ages18 or older and were 
able to read and write English at a 6
th
 grade level.  
Inclusion and Exclusion Criteria 
Inclusion criteria.  Individuals participating in the study were 18 years of age or 
older to avoid other motor neuron diseases of genetic origin that mimic ALS. Participants 
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had the capacity to understand the self-report questionnaires, and were able to read and 
write English on a 6
th
 grade level. Participants were males or females who had been 
diagnosed with amyotrophic lateral sclerosis by a healthcare professional, and were at 
any stage in the disease process. 
Exclusion criteria.  Participants under the age of 18, or those not diagnosed with 
ALS were excluded. Screening procedures determined inclusion and exclusion criteria 
The survey was hosted on the internet in public domain. Control over the numbers 
of people who accessed the survey was limited, including verification of an ALS 
diagnoses, and those who were completing the survey. The demographics portion of the 
survey asked participants to identify ALS symptom onset, date of diagnosis, and site of 
ALS symptom onset to verify diagnosis in this open enrollment study.  
A survey with incomplete measures on the ALSSQOL-R, containing missing data 
of more than 3 missing responses were discarded from the study analysis because a total 
QOL score could not be calculated.  
Surveys without dates of symptom duration for ALSFRS-R to allow calculation 
of length of illness were not included in the analysis. 
Analysis of Risk / Benefit Ratio.  This study carried minimal risk to the 
participants.  There were no reports of physical discomfort, and there were no known 
physical risks associated with this study. Participants may have experienced some 
emotional discomfort in filling out the survey because of reflection on quality of life and 
physical functioning. Participants were instructed at the beginning of the survey that 
participation was voluntary; they were able to take breaks as needed, or stop their 
participation in answering the questionnaire at any time.  Risks were described in a brief 
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introductory description at the beginning of the survey. The survey took approximately 
sixty minutes to complete.  
 No direct benefit was experienced by participants in this study.  Results of the 
research may improve future treatment approaches, of development of treatment 
protocols, and improve the quality of life of individuals with ALS. In particular, results of 
this study may lead to a better understanding of the reasons why ALS patients access 
multidisciplinary clinics, of perceived advantages of this approach to care, and how 
multidisciplinary clinics improve patient quality of life. The survey may provide insight 
into the reasons why individuals with ALS do not attend a multidisciplinary clinic and the 
factors that affect their quality of life.  
Procedures for maintaining confidentiality 
This research involved anonymous responses to a web based survey. The research 
was voluntary and the responses are anonymous. All participants had to be 18 years or 
older to participate in the survey. No coding system was used to identify individuals, and 
no identifying IP addresses were collected. The health information collected was 
protected by law, as explained in the participating institutions privacy notices. The 
research records were electronically stored and the data were kept in a password 
protected computer file. In the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared.  
Recruitment 
The web based survey was hosted on the internet, using the survey software,“Survey 
Monkey”. Control over those who accessed the survey and the number of people 
completing the survey was limited. The link to the survey was hosted on the Penn State 
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Hershey Medical Center ALS clinic website, National ALS Association website, and 
Patientslikeme.com. When the participant completed the survey the web browser was 
directed to the homepage of the Penn State MSHMC ALS Clinic 
(http://www.alsphiladelphia .org/pennstatehershey/). 
Plan for Informed Consent Procedures 
Research with human subjects requires prior consent. In order to assure that potential 
study participants fully understood what their participation entailed, informed consent 
was obtained from each individual involved in the study. As standard in informed consent 
procedures, participants were fully informed about the procedures, and benefits and risks 
involved in the proposed research. The main risk in the study was psychological because 
participants were asked personal questions about physical functioning and quality of life, 
questions routinely asked by health care professionals. Participants may have found the 
study pertaining to their experiences, thoughts, and feelings interesting and valuable. 
Health information was collected, and protected by law, as explained in the Milton S. 
Hershey Medical Center Privacy Notice. A copy of the privacy notice was available upon 
request. 
Participants were required to demonstrate informed consent prior to participating 
in web-based survey research. Participants reviewed the explanation about the purpose of 
the study, procedures to be followed, and explanation of the risks and benefits of 
participating in the study. Individuals were asked to click on a button providing consent 
to participate. Thus, by performing the specific action of clicking on the “continue” 
button the participant clearly indicated that they had fully read information about the 
study. Participants were given access to Milton S. Hershey Medical Center Privacy 
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Notice, and they provided informed consent prior to viewing or completing any questions 
in the study. Taking part in this research was voluntary; participants were informed of 
their right to stop the survey at any time, and did not have to answer any questions for 
any other reason.   
Measures 
Instruments 
ALS Specific Quality of Life Questionnaire-Revised 
ALS-specific Quality of Life Questionnaire-Revised (ALSSQOL-R) is a 46 item 
questionnaire using a 0-10 point Likert scale, with 0 being the least desirable situation, 
and 10 the most desirable. The instrument contains 6 factors: (1) Negative Emotion, (2) 
Interaction with People and the Environment, (3) Intimacy, (4) Religion, (5) physical 
symptoms, and (6) bulbar function. Completion time averages 15 minutes. The 
ALSSQOL-R demonstrates concurrent, convergent, and discriminate validity for the 
overall instrument, and convergent validity for the subscales (Simmons, 2006). 
ALS Functional Rating Scale-Revised 
 The ALS Functional Rating Scale-Revised (ALSFRS-R) is a ALS disease specific 
measure of global functioning (Montes et al., 2006) The rating scale is easily 
administered by the patient; it predicts survival time, and has been shown to be 
reproducible when administered by an evaluator. The 12 item questionnaire provides a 
score from worst function O to normal function 4 for each item. Total scores range from 
0 to 48. Montes (2006) found the scale to be reliable when administered by an evaluator 
or patient. The ALSFRS-R questionnaire has shown good reliability and sensitivity to 
change over time. The ALSFRS-R predicts survival time, and correlates measures of 
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function and strength. Test results are reproducible when administered by the patient or 
evaluator and has been utilized in previous clinical trials (Montes et al., 2006). Kaufman 
and colleges found the ALSFRS-R to have exceptional intra rater and inter rater 
reliability when used as a primary outcome measure in a multi-center ALS trial. Scores 
are valid when compared with patient self ratings, and the instrument is sensitive to 
change. The self-administered version was used for this study. 
Social Problem-Solving Inventory – Revised Short 
The Social Problem-Solving Inventory – Revised Short version (SPSI-R: S) is a 
25 item, self-report measure of social problem solving skills, and evaluates individual 
ability to resolve problems in everyday life (D’Zurilla, Nezu, & Mayeu-Olivares, in 
press). Completion time averages ten minutes. The measure asks subjects to report typical 
responses to current problems in general on a 5 point Likert scale, ranging from “not at 
all true of me” to “extremely true of me”. The measure is based on a five dimensional 
model of problem solving. The inventory has a total of five scales; two scales are 
constructive, and three are dysfunctional dimensions of problem solving. Constructive 
dimensions are Positive Problem Orientation (PPO) and Rational Problem Solving (RPS). 
The PPO scale relates to an individual’s constructive and problem solving cognitive set, 
and the RPS scale evaluates the rational and systematic application of effective problem 
solving strategies and performance. Dysfunctional dimensions are Negative Problem 
Orientation (NPO), Impulsivity/Careless Style (ICS), and Avoidance Style (AS). The 
NPO scale measures a dysfunctional or inhibitive cognitive emotional set. The ICS scale 
evaluates a deficient problem solving pattern characterized by active attempts to apply 
problem solving strategies and techniques that are impulsive and incomplete. The AS 
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scale assesses defective problem solving patterns characterized by procrastination, 
passivity or inaction. Each dimension converts a raw score to a standard score with a 
mean of 100 and a standard deviation of 15. Higher scores on the two adaptive scales, 
PPO and RPS, indicate potentially greater constructive or effective problem solving skill, 
and psychological well being. Higher scores on the three dysfunctional scores NPO, ICS, 
AS indicate potentially defective problem solving.  
Procedure 
 Advertisement and recruitment of participants for the on-line, web-based survey 
was conducted through collaboration with the ALS Association, their affiliates, 
Patientslikeme.com, and Penn State Milton S. Hershey Medical Center. The ALS 
Association is a national organization with affiliate networks composed both of chapters 
and free standing support groups throughout the United States. A chapter is a 
multifaceted organization responsible for carrying out the mission of the ALS National 
Association goals and objectives and provides a variety of patient care initiatives. An 
ALS support group is a collection of people that meet for the purpose of providing 
mutual support and information to people with ALS, their care givers, and families.  
Penn State Milton S. Hershey Medical Center provided a secure on-line server for 
the research, collected the on-line survey results, and stored data in a secure area at HMC. 
Through the various contacts of HMC with ALS society, ALS patients, and Center 
Directors, flyers and letters announcing the research were disseminated. HMC advertised 
the research through their website, and newsletter.  
A Research flyer and letter announcing the research project was sent to the 
National ALS Association. These letters and information flyers were distributed to local 
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chapters. The Center Directors disseminated the flyers and letters directly to individuals 
registered with the chapters, to patients diagnosed with ALS, and to leaders of support 
groups throughout the United States. The Chapters and executive directors notified 
patients registered with chapters and asked support group leaders to notify individuals in 
group support.  
Written notification of the study was provided in the form of a letter and study 
flyer. Information provided detailed the research objectives, directions in how to access 
the survey through the URL of the research study internet site, and a point of contact for 
the study coordinator concerning questions or concerns regarding the study. The 
announcement of the study was posted by website and newsletter through the Greater 
Philadelphia Chapter of the ALS Association, the Western Pennsylvania, and West 
Virginia Chapter of the ALS Association, and the Penn State Milton S. Hershey ALS 
Clinic. 
The announcement provided participants with specific instructions on how to 
access the website, information on goals and objectives of study, as well as risks and 
benefits. Participants reviewed consent procedures, and clicked the button marked 
“continue” to indicate informed consent. Participants accessed the site providing 
informed consent, and began to answer the questionnaire. After completion of the survey, 
participants were instructed to click the “finish” button to indicate completion of the 
survey and allow the transmission of results to a secure server at Hershey Medical 
Center. The web browser redirected participants to the home page of Penn State MSHMC 
ALS clinic after completion of the study. 
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Chapter 5 
Results 
A total of 403 ALS patients started the on line survey from April 2009 to January 
2010. Individuals self- identified as attendees of a MDC (N=240), or non attendees 
(N=89). Participants who did not answer the first question (N=74) were excluded as 
missing data. Question one, “How often have you attended a multidisciplinary clinic?” 
differentiates attendees and non attendees; thus, these respondents were unable to be 
classified either as attendees or non attendees, and were not included in the remainder of 
the analyses (see Table 1).   
Descriptive statistics were used to examine the demographic characteristics of 
individuals who attend multidisciplinary ALS clinics, and those who do not attend such 
clinics, in order to look for descriptive differences between the two. Due to missing data 
on some measures, reported N values may vary between analyses. 
Of the 233 attendees who reported gender, 62.7% (N=146) were male and 37.3% 
(N=87) female. Of the 84 non attendees who reported gender, 60.7% (N=51) were male 
and 39.3% (N=33) female. Differences between groups by gender were not significant 
(Phi Coefficient = -.018, p = .752). Male to female ratio of ALS patients is estimated at 
1.3 to 1.6:1, thus the present sample was representative of the general population in terms 
of gender (Valdmanis & Rouleau, 2008). Mean age for both groups was approximately 
58 years (nonattenders, N=83, X = 58.6, SD=10.01; attenders, N=235, X=57.6, 
SD=10.05), with no significant differences between groups based on age (t = .763 
(144.36), p. = .447). ANOVA results showed a significant difference in mean symptom 
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duration between groups (attendees, N=233, X=59.8, SD=62.1; non attendees N=83, 
X=80.9, SD=84.4; F = 5.769, p. = 0.017).   
Table 1 
________________________________________________________________________ 
 
Categories       Frequency  Percent 
                _________________________ 
 
Attendees 
 
Never, but I have a scheduled appointment or plan    18     4.5 
to attend in the upcoming future  
 
One time, and I have a scheduled appointment    20     5.0 
or plan to attend in the upcoming future 
 
More than 1 time, and I plan to continue my    202   50.1 
treatment at a MDC 
 
Non Attendees 
 
Never, and I have no plans to attend a MDC     41   10.2 
 
One time for a single diagnostic visit, but I have no    15     3.7  
plans to attend again 
 
More than one time, and I do not plan to continue    33     8.2 
my treatment at a MDC 
 
Did not answer question “missing”      74   18.4 
 
Presented in Table 2, participants were similar in regard to site of ALS symptom 
onset: 1) limb, 2) bulbar, and 3) breathing (Phi Coefficient = .085, p = .319). No 
differences were found in regard to sporadic and familial ALS (Phi Coefficient = .024, p 
= .664). Most cases of ALS are sporadic; and five to ten percent are familial (Valdmanis 
& Rouleau, 2008). Participants who responded yes to, “Do you have a family member 
with ALS?” were representative of the general population in regard to sporadic or 
familial ALS.  
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Table 2 
 
Site of ALS Symptom Onset - Attenders 
________________________________________________________________________ 
Categories         
 
                Frequency Valid Percent 
 
Limb        174   74.4 
 
Bulbar          59   25.2 
 
Breathing           1       .4 
 
Site of ALS Symptom Onset – Non Attenders 
________________________________________________________________________ 
Categories         
 
                Frequency Valid Percent 
 
Limb        69   82.1 
 
Bulbar        15   17.9 
 
Breathing         0     0.0 
 
Do you have other family members with ALS? - Attendees 
________________________________________________________________________ 
Categories         
 
                Frequency Valid Percent 
 
Yes          16     6.9 
 
No        216   93.1 
 
Do you have other family members with ALS? – Non Attendees 
________________________________________________________________________ 
Categories         
 
                Frequency Valid Percent 
 
Yes          7     8.3 
 
No        77   91.7 
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Individuals who attend a MDC reported higher utilization of the following 
medications and assistance: 1) antidepressants, 2) medication to reduce 
cramping/spasticity, 3) sleeping medications, and 4) augmentative communication 
devices. 
Non attendees reported higher utilization in the following areas: 1) medications to 
reduce saliva production, 2) pain medication, 3) treatments for constipation, 4) 
Percutaneous Endoscopic Gastronomy (PEG) or feeding tube, 5) tracheostomy or 
mechanical ventilation, and 6) power wheel chair. Non attendees also reported higher 
incident of receiving no treatment.   
Attendees and non attendees report similar usage of treatment for 1) urinary 
urgency, 2) NIPPV or BiPAP, 3) complimentary or alternative medicine, and 4) “other” 
treatments (see Table 3).  
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Table 3 
 
What treatments do you use for your ALS? 
Attendees and Non Attendees 
________________________________________________________________________ 
Categories         
    Attendees  Non attendees  P-value             
    N, Percent (%) N, Percent (%) 
        ____________________________________ 
         
 
Riluzole (Rilutek)  N=138, (57.5)  N=36, (40.4)   P=0.006* 
 
Antidepressants  N=104, (43.3)  N=31, (34.8)  P=0.164 
 
Medications to reduce  N=43, (17.9)  N=19, (21.3)  P=0.480 
saliva production 
 
Medications to reduce  N=79, (32.9)  N=25, (28.1)  P=0.403 
cramping/spasticity 
 
Pain medications  N=44, (18.3)  N=31, (34.8)  P=0.002* 
 
Sleeping medications  N=75, (31.3)  N=25, (28.1)  P=0.580 
 
Treatments for constipation N=60, (25.0)  N=26, (29.2)  P=0.440 
 
Treatments for urinary N=27, (11.3)  N=10, (11.2)  P=0.997 
urgency 
 
Percutaneous Endoscopic N=43, (17.9)  N=20, (22.5)  P=0.351 
Gastronomy (PEG) or  
feeding tube  
 
NIPPV or BiPAP  N=69, (28.8)  N=26, (29.2)  P=0.934 
 
Tracheostomy or Mechanical N=9, (3.8)  N=8, (9.0)  P=0.057 
ventilation 
 
Augmentative   N=61, (25.4)  N=15, (16.9)  P=0.102 
communication device 
 
Power Wheel Chair  N=106, (44.2)  N=47, (52.8)  P=0.163 
 
Experimental medications N=35, (14.6)  N=10, (11.2)  P=0.432 
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No treatment   N=10, (4.2)  N=9, (10.1)  P=0.040 
 
Complementary and   N=70, (29.2)  N=26, (29.2)  P=0.993 
Alternative medicine  
(includes supplements, massage,  
holistic medicine, chiropractic care,  
acupuncture, etc) 
 
Other (please specify)  N=192, (80.0)  N=71, (79.8)  P=0.483 
Note. * = p <.05. 
Individuals who attended a MDC reported higher utilization of health care 
professionals: 1) neurologist, 2), nurse, 3) respiratory therapist, 4) physical therapist, 5) 
occupational therapist, 6) mental health professional, 7) social worker, 8) dietician, and 9) 
speech therapist.  
 Individuals who do not attend a MDC report higher levels of health care 
utilization: 1) pastoral care chaplain, 2) complementary and alternative medicine, 3) 
hospice services and 4) experimental medications. 
 Clinic and non clinic attendees report similar utilization of: 1) pulmonologist, and 
2) in home care (see Table 4). 
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Table 4 
 
Response for Attendees and Non Attendees 
 
Do you use or have your been referred to any of these health care providers as part of 
your care for ALS? Check all that apply  
________________________________________________________________________ 
         
Categories   Attendees  Non attendees  P-value 
    N, Percent (%)      N, Percent (%) 
        ____________________________________ 
         
Neurologist   N=196, (81.7)  N=64, (71.9)  P=0.053 
 
Nurse    N=105, (43.8)  N=19, (21.3)  P=0.001* 
 
Respiratory Therapist  N=118, (49.2)  N=25, (28.1)  P=0.001* 
 
Pulmonologist   N=96, (40.0)  N=36, (40.4)  P=0.941 
 
Physical Therapist  N=177, (73.8)  N=42, (47.2)  P=0.001 
 
Occupational Therapist N=144, (60.0)  N=37, (41.6)  P=0.003* 
 
Mental Health Professional N=53, (22.1)  N=15, (16.9)  P=0.298 
 
Social Worker   N=109, (45.4)  N=25, (28.1)  P=0.004* 
 
Pastoral Care or Chaplain N=34, (14.2)  N=17, (19.1)  P=0.272 
 
Dietician   N=107, (44.6)  N=14, (15.7)  P=0.00* 
 
Speech Therapist  N=126, (52.5)  N=34, (38.2)  P=0.021 
 
Complimentary and   N=36, (15.0)  N=17, (19.1)  P=0.369 
alternative medicine 
(Chiropractors, Naturopathic  
Doctors, Acupuncturists, etc.) 
 
In Home Care   N=68, (28.3)  N=25, (28.1)  P=0.965 
 
Hospice Service  N=15, (6.3)  N=15, (16.9)  P=0.003* 
 
Experimental Medications N=35, (14.6)  N=10, (11.2)  P=0.432 
 
Note. * = p <.05. 
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In order to compare group means, Multivariate Analysis Of Variance 
(MANOVA) was conducted on the primary outcome measures of total ALSSQOL-R 
scores, total ALSFRS-R scores, and total SPSI-R scores between ALS patients who 
attend multidisciplinary clinics and those who do not attend clinics. A priori power 
analysis estimates a required sample size of 210 participants for one-way MANOVA with 
an effect size of .25 and a significance level of α = .05.  
Analyses were conducted with varying numbers of participants who meet 
inclusion criteria. ANOVA results showed a significant difference in overall quality of 
life in individuals who attend a MDC compared with non attendees, based on the total 
ALSQOL-R average score. ANOVA results also showed significant differences in 
participants who attend versus participants who do not attend a MDC on the Intimacy, 
Physical Function, and Bulbar Function subscales of the ALSQOL-R. ANOVA results 
revealed no significant difference between groups with regard to Negative Emotion, 
Interaction with people and the Environment, and Religiosity subscales (see table 5). 
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Table 5 
ALSSQOL-R 
Attenders and Non Attenders 
________________________________________________________________________ 
Category         
    Attenders   Non attenders            P-value 
    Mean, (SD), range  Mean, (SD), range  
        ____________________________________ 
ALSSQOL-R    N=229, X=6.4   N=81, X=5.7           P=0.004* 
Average Total   SD=1.6, 0.8-9.6  SD=1.7, 0.2-9.2 
 
Negative Emotion    N=220, X=6.3  N=73, X=5.8           P=0.062 
    SD=2.0, 1.1-10.0  SD=1.9, 1.2-9.4 
   
Interaction with people N=221, X=7.8   N=72, X=7.4           P=0.108 
and the Environment  SD=1.7, 2.3-10.0  SD=1.5, 4.2-10.0 
     
Intimacy   N=210, X=5.9   N=67, X=5.3           P=0.021* 
    SD=2.0, 1.1-10.0  SD=2.1, 0.4-9.9 
 
Religiosity   N=223, X=5.4   N=75, X=6.3         P=0.069 
    SD=3.7, 0.0-10.0  SD=3.6, 0.0-10.0 
 
Physical Function  N=224, X=6.2   N=78, X=5.3         P=0.004* 
    SD=2.0, 0.0-9.8  SD=2.4. .3-10.0 
 
Bulbar Function  N=224, X=6.6   N=77, X=5.7         P=0.010* 
    SD=2.6, 0.4-10.0  SD=2.7, 0.0-10.0 
 
Note. * = p <.05. 
 
 A total of 280 participants met inclusion criteria, and were included in the 
ALSFRS-R analysis. ANOVA results showed a significant difference between the two 
groups. Participants not attending a MDC reported overall better levels of physical 
function, as measured by the ALSFRS-R (see table 6). 
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Table 6 
 
ALSFRS-R Total 
Attendees and Non Attendees 
________________________________________________________________________ 
Attend Status  N Mean  Standard Deviation F       P-value 
                                                        
_______       ____________________________________ 
Attendees  206 18.7     9.8  15.272      P=0.000 
 
Non attendees    74 24.0   10.3 
 
Social Problem Solving Inventory – Revised: Short Form 
Overall, a smaller number of participants (N = 274) completed the SPSI-R who 
also responded to the attend status. Attendee’s and non attendee’s mean scores on the 
SPSI-R and subscales were within average range compared with the SPSI-R normative 
sample, and did not differ significantly from one another (F = 1.599, p=.147). 
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Table 7 
Social Problem Solving Inventory-R: S 
Attendees and Non Attendees 
________________________________________________________________________ 
Category         
    Attendees   Non attendees            P-value 
    (N), Mean, (SD)  (N), Mean, (SD)  
        ____________________________________ 
PPO Scaled score  N=214,   N=69,                  P=0.699 
    X=103.43, SD=16.08  X=102.62, SD=16.67 
 
Negative Problem   N=210,   N=71,                        P=0.362 
Orientation Scaled  X=95.31, SD=14.17  X=96.85, SD=15.65 
   
Rational PS Scaled Score N=213,   N=71,                    P=0.032 
    X=104.44, SD=14.65  X=99.67, SD=15.71 
     
ICS Scaled Score  N=214,   N=71,                  P=0.069 
    X=97.21, SD=13.71  X=100.69, SD=14.47 
     
AS Scaled   N=212,   N=70,                    P=0.446 
    X=96.13, SD=12.90  X=97.45, SD=14.58 
     
SPSIR Scaled   N=206,   N=68,                  P=0.054 
    X=105.72, SD=12.94  X=102.08, SD=14.95 
    
Qualitative Analysis 
Data Coding 
Participant response data were individually and collectively coded for analysis by 
the principal investigator and two doctoral level students in clinical psychology from 
Philadelphia College of Osteopathic Medicine. Free text responses were reviewed and 
categorized based on similarities. Individual responses identifying multiple themes were 
listed in multiple categories. Group processes, thoughts, and impressions of the coders 
were recorded by the investigator and were reported in manuscript form. Group 
consensus guided the process of drawing conclusions of emergent themes, providing 
greater validity to participant response data. A manuscript of the categories was 
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submitted to the larger ALS research team for comment and feedback. Cross comparisons 
of themes emerged in coding and were utilized to identify commonalities or differences. 
Subsequent responses of attendees and non attendees were differentiated and separated 
for qualitative analysis of respective viewpoints of treatment experiences. The purpose of 
the analysis was to evaluate similarities and differences of patients who attend or who do 
not attend a MDC.  
Qualitative Results 
Reasons for attending a multidisciplinary clinic 
 “If you do go to a multidisciplinary clinic, please tell us why you go. Please give 
us as much information and detail as you can.”  
228 participant responses were coded; 6 responses were excluded as “N/A” or 
reported as “non attending”, (N=222). Convenience / travel / time was the predominant 
response (N=73, 32.9%), validating the fact that access to care standards influence 
quality of life. One participant commented on aspects of a MDC, and effect on his or her 
quality of life.  
“I have one appointment once every three months and all my 
health issues are addressed. If you will, it is one stop shopping rather than 
a multitude of appointments that wears greatly on me and my family. Also 
with full focus and expertise in the field they are able to help my issues 
from pain to frustration with lost abilities. The clinic also deals with other 
health issues; at my last appointment I had broken my arm and two 
vertebrae from a fall. Even though I had seen a doctor for the fractures 
they recommended and scheduled appointments for other procedures on 
my back. I decided to follow through with the recommended procedures 
which indeed helped with the pain I was dealing with. The ability to have 
all aspects of my changing conditions reviewed at one time and modified 
medical care immediately recommended regardless of the medical 
specialty required greatly simplifies my life. Bottom line they all care, 
share their individual observations at a team meeting and immediately 
recommend how to improve the quality of my life.” 
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 Specialist (N=70, 31.5%) was the second highest response given as a reason to 
attend a MDC. Integrative care (N=49, 22.1%) was the third highest.  
“The neurologist is a specialist in ALS. Appropriate PT, OT, RT, 
social services, etc., are provided by people with experience and 
competence in ALS. References for equipment are provided, including 
loan and rental equipment. The PT brought in the AFO vender and the 
company that fitted me for a power chair. There is outstanding knowledge 
of what Medicare and supplemental insurance will cover. There is prompt 
care and genuine concern and personal knowledge of me as a patient.” 
 
“I go because I am given the attention and care from each 
specialist. I am never rushed it’s a one on one time with them. They also 
make recommendations and suggestions and make further appointments 
for various things as I need them, like physical therapy, sleep study, lung 
evaluations, etc. If I need any supplies they are brought to me at my home 
from their loan closet. I have gotten a cane, a walker, a ream for the front 
door, a text board to help with my speech difficulties, a shower stool. All 
of this at no cost to me, if I need anything or any advice I have a registered 
nurse who comes to the house if need be. I feel that I matter as a person. I 
have been to two multi-disciplinary clinics and will go every three months. 
I think it’s important too, that each person I see meets with the others to go 
over my case afterwards.”  
 
Participants found gaining information and knowledge (N=40, 18%), and evaluate 
progression (N=26, 11.7%) valuable facets of a MDC.  
“MDC was set up by the Mayo Clinic, at the Mayo Clinic. At each 
Clinic we see the specialists that can help us deal with each of our 
problems. For instance, at the latest clinic I saw the neurologist who did 
another evaluation of my progression. We saw a speech therapist, who 
evaluated my ability to speak. We met with a Physical therapist who 
measured me for a wheelchair. And we met with a Social Worker who set 
us up for attending Support Groups and connecting with people who could 
assist us in getting the equipment I will need shortly.” 
 
“They provide most recent information available. Very helpful in 
giving suggestions to help me with daily functioning and to be able to 
maintain as much independence as this disease will allow. Helps me to 
keep track of all new research and trials that might be available for me to 
participate if I am eligible.”   
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The final categories include 1) support and trust, 2) research and clinical trials, 3) 
cost and insurance coverage, 4) equipment, 5) diagnosis confirmation, and 6) expertise 
(see Table 9). 
Table 9 
 
If you do go to a Multidisciplinary Clinic, please tell us why you go. Please give us as 
much information and detail as you can. 
 
________________________________________________________________________ 
 
Categories    Number of Responses   Percent 
 
________________________________________________________________________ 
 
Convenience / Travel / Time   73    32.9 
 
Specialist     70    31.5 
 
Integrative care    49    22.1 
 
Gaining information and knowledge  40    18.0 
 
Evaluate progression    26    11.7 
 
Support and trust    26    11.7 
 
Research and clinical trials   22      9.9 
 
Referrals     14      6.3 
 
Cost and insurance coverage     7      3.2 
 
Equipment       5      2.3 
 
Diagnosis confirmation     3      1.4 
 
Expertise       2      0.9 
 
Advantages and disadvantages of attending a multidisciplinary clinic 
 “Please tell us about any advantages or disadvantages from receiving care from a 
multidisciplinary clinic. Give as much detail and information as you can.” 
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 A total of 215 participants responded to this open ended question; 25 responses 
were excluded from the coding as incomplete. A total of 190 completed responses 
identified 244 advantages, and 101 disadvantages of receiving care at a MDC.  Coders 
first stratified the two groups of responses as advantages and disadvantages. Responses in 
each group were coded and placed in a category. 
Participant responses for MDC advantages were coded and placed in seven 
categories. The primary category convenience, integrated care / travel time (N=94) 
illustrates the importance of multidisciplinary care received at a MDC.  
“The team approach gives me a sense of quality care that I feel I 
could not get from a single doctor alone. ALS affects so many of the 
body’s muscles and systems that having the team meet with me enhances 
my quality of life. The specialists know things that can help me to manage 
my care and make things easier for me.” 
 
‘The facility is downtown. I live out in the suburbs so commuting 
to the office is perhaps not quite as convenient as it was being seen by a 
local neurologist, but I don’t really feel like there’s any comparison in 
terms of the quality of the care and its sophistication that I received. Again 
the advantages are that it provides one stop shopping. You are able to see 
the whole range of people providing care to you in one outing. I also think 
it’s an advantage that they are all working at one centers so they can 
coordinate their activities in the care that they provide to me and the 
attention that they give to my wife.”  
 
Remaining categories of: 1) resources and information, 2 clinical expertise, 3) 
general support, 4) monitor progression, 5) treatment research and clinical trial, and 6) 
social support were recognized as advantages associated with MDC attendance (see 
Table 10). 
“They help you understand what’s going on and what you can 
expect. Help get the correct (wheel chairs, walkers) things in general to 
make it easier to go on. Their advice both on the phone and over the 
internet take care of most any question. As this is really completely 
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unknown to me and my wife they have been more help than they could 
ever believe. Even the smallest question is always taken care of.”  
 
 “The advantages are that all the medical professionals are at one 
location. They know more about the disease than any other doctor that I 
had been to.” 
“My wife and I cannot imagine this disease without the experts in 
all divisions: Speech & swallowing; PT, OT, emotional therapy, sleep 
experts etc. plus at BID we have noon lunch with fellow patients in a 
social setting.” 
 
Participant responses were coded into nine categories related to disadvantages of 
attending a MDC. Two primary categories emerged, viz., travel distance (N=29), and a 
long exhausting day (N=24),  
“It’s exhausting for the patient! Especially if you have to travel 
about 400 miles in a day.” 
 
“I did not like the wait time and that it took almost a whole day to 
be seen by several practitioners. I found it fatigues me to be in this 
environment almost a whole day.” 
 
“Went to MDC from time of diagnosis till January of this year 
when had surgery for feeding tube and vent. Getting to clinic is too 
difficult now, and the only time we go out is for medical necessity or 
major family event. If going out were easier, we would still go to the 
clinic.” 
 
 
Participants identified rigid and generic (N=15) wait time (N=14), schedule 
(N=7), limits of services and treatment (N=5), do not like doctor (N=4), unnecessary 
services (N=2), and environment (N=1) as disadvantages to attending a MDC (see Table 
10) 
”There is a rote protocol for all patients without regard to individual 
variations which are many.” 
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Table 10 
 
Please tell us about any advantages or disadvantages from receiving care from a 
Multidisciplinary Clinic. Give us as much detail and information as you can. 
 
________________________________________________________________________ 
 
Categories        Number of Responses  
________________________________________________________________________ 
 
Advantages______________________________________________________________ 
 
Convenience (integrated care / travel time)     94   
 
Resources and information       44 
 
Clinical expertise        43 
 
General support/support from other patients     32 
 
Monitor progression        15 
 
Treatment research and clinical trials      11 
 
Social support           5 
 
 
Disadvantages____________________________________________________________ 
 
Travel distance        29 
 
Long exhausting day        24 
 
Rigid and generic        15 
 
Time / wait time        14 
 
Schedule           7 
 
Limits of services and treatment        5 
 
Do not like doctor at MDC         4 
 
Unnecessary services          2 
 
Environment           1 
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Rationale for not attending a multidisciplinary clinic 
 “If you do not go to a multidisciplinary clinic please tell us why. Please give us as 
much information as you can.” 
100 individuals responded; 25 responded with “N/A” or incomplete response and 
were excluded from the coding. Travel (N=19, 25.3%) was recognized as the primary 
category for not attending a MDC 
“I don’t go to a Multidisciplinary Clinic because it’s in San 
Francisco and that’s just too difficult for me to maneuver physically. It’s 
tiring to drive in the commute even with my special van and motorized 
wheelchair. Very little parking for handicapped vans with ramps. Regular 
cars with placards park in them too and that almost always leaves me 
searching for a space. I just can’t handle it.” 
 
A number of participant responses were coded in uninformed, not referred (N=13, 
17.3%), and were unaware of the existence of a MDC. 
“I have not been spoken to about any potential benefits of going 
and I would be interested to see what a clinic visit could do for me.” 
 
Remaining participant responses were coded in the following categories: 1) felt 
like a lab rat, 2) depressing, no cure, 3) local doctor nearby, 4) didn’t like doctor, 5) tiring 
/ difficult,  6) none in area, 7) length of clinic time / poor clinic organization, 8) attend 
VA, 9)  no need to attend, 10) cost and insurance, and 11) sub theme, utilizing alternative 
medications (see Table 11). 
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Table 11 
 
If you do not go to a Multidisciplinary Clinic please tell us why. Please give us as much 
information as you can.  
 
________________________________________________________________________ 
 
Categories     Number of Responses  Percent 
 
________________________________________________________________________ 
 
Travel       19   25.3 
 
Uninformed, not referred    13   17.3 
 
Felt like a lab rat, depressing, no cure    9   12.0 
 
Local doctor nearby       8   10.7 
 
Didn’t like doctor       8   10.7 
 
Tiring / difficult       7     9.3 
 
None in area        6     8.0 
 
Length of clinic time / poor clinic organization   6     8.0 
 
Attend VA        5     6.7 
 
No need to attend       5     6.7 
 
Cost and insurance       4     5.3 
 
Sub theme, utilizing alternative medications    2     2.7 
 
Circumstances influencing attendance at a multidisciplinary clinic 
“If you do not attend a multidisciplinary clinic, under what circumstances might 
you attend an ALS clinic? Please give us as much information as you can.” 
A total of 87 participants responded; 21 responded with “N/A” or an incomplete 
response and were excluded from the coding (N=66). Nine categories were identified 
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from participant responses as circumstances influencing attendance at an MDC. However 
(N=6) participants indicated they would not consider attending a MDC.  
The primary category was travel, closer to home, access (N=36, 54.5%). One 
participant response suggested willingness to attend a MDC if it were closer to home. 
If there was a clinic in my area I would attend regularly. But I live 
in a rural area and find the drive too tiring. My twice a year trip to my 
neurologist and trips to my respirologist, when the appointments can’t be 
made for the same day, are all I can manage.” 
“Money is the biggest factor, plus is hard to travel with all the 
equipment, such as pwr wheelchair, voice amp and BIpap unit. Plus I 
think the closest clinic is 400 miles away.” 
 
 Other responses suggest participants were unaware or lacked information 
concerning the benefits of a MDC and were coded in category, understood function 
(N=9, 13.6).  
“Well, I would want to learn about it first. I am certainly open to 
the idea.” 
  
 “Would like to have information and an invitation.” 
 
 “When the time comes that I need help breathing or using my 
limbs. I have limited use of my left arm, fingers and left leg but still get 
around, slowly, without the use of a wheelchair. ALS of Cleveland and 
MDA of Toledo are both ready when I am.” 
 
Participants (N=7) indicated the potential of attending a clinic if physical health 
declined, considering that MDC has specialized treatments and providers. “When I start 
having difficulty breathing, talking, swallowing, etc., I will probably discuss the 
feasibility of attending the clinic with my neurologist,” and “I might attend a 
Multidisciplinary clinic for my breathing and speech problems.” 
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The remaining participant responses were coded in the following categories: 1) 
cure, 2) cost, 3) invitation, referral from a health care provider, 4) socialization, 5) trust 
doctor, and 6) less wait time (see Table 12).  
Table 12 
 
If you do not attend a multidisciplinary clinic, under what circumstances might you 
attend an ALS clinic? Please give us as much information as you can. 
 
________________________________________________________________________ 
 
Categories     Number of Responses   Percent 
 
________________________________________________________________________ 
 
Travel, closer to home, access   36    54.5 
 
Understood function of MDC     9    13.6 
 
Health declined and need specialized treatment  7    10.6 
 
No chance I’ll go, no hope     6      9.1 
 
Cure        5      7.6 
 
Cost        4      6.1 
 
Invitation, referral from a health care provider  3      4.5 
 
Socialization       3      4.5 
 
Trust doctor       1      1.5 
 
Less wait time       1      1.5 
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Travel and distance considerations  
 “How does travel distance to a multidisciplinary clinic or other health care 
professional influence your treatment decisions? Please give as much information as you 
can.” 
239 individuals responded; 10 responded with “N/A” or an incomplete response 
and were excluded from the coding (N=229). The majority of participant responses 
indicated that travel distance is not a factor in treatment decisions (N=144, 62.9%), In 
fact, one participant drives 225 miles to attend a MDC. 
“No I was told they were the best place so the distance of 225 
miles each way didn’t bother me a bit.”   
 
“Going to a multiple disciplinary clinic is hard on someone in a 
wheelchair. There is no way that I could get the care that I get in Columbia 
South Carolina. The MDA sponsored clinic in Charlotte, North Carolina 
an unquestionably get better care to ALS patients.” 
 
“I don’t mind at all traveling this distance to the clinic because all 
personnel are very caring and empathetic. They all treat patients like their 
old friends with welcoming gesture. They take all patients as though their 
cases are most important one. Besides they have all the experts there in 
one place. I don’t have to go different places for different appointments, 
especially for ALS patient who usually have problem in moving.”  
 
 Participants (N=85) indicated that travel distance does influence treatment 
decisions. Responses were coded into six categories: 1) travel barriers: coordination, 
expense, and physically uncomfortable, 2) stage of disease progression make travel more 
difficult, 3) fatigue, 4) proximity to physician affects health care decisions, 5) frequency, 
and 6) time away from work (see Table 13).  
“It has everything to do with it. Traveling to San Francisco almost 
any time of the day is difficult and time consuming. Also it’s extremely 
hard to park a modified can in a disabled parking spot because cars are in 
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them. The drive to and from is tiring, and I hate to ask someone to give up 
almost a whole day to go with me.” 
 
Table 13 
 
How does travel distance to a Multidisciplinary Clinic or other health care professional 
influence your treatment decisions? Please give as much information as you can.  
 
________________________________________________________________________ 
 
Categories    Number of Responses   Percent 
 
________________________________________________________________________ 
 
Travel distance is not a factor   144    62.9 
in treatment decisions  
 
Travel barriers: coordination, expense,   48    20.9 
and physically uncomfortable 
 
Stage of disease progression     13      5.7 
makes travel more difficult 
 
Fatigue       10      4.3 
 
Proximity to physician affects    10      4.3 
health care decisions 
 
Frequency         3      1.3 
 
Time away from work       1      0.4 
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Chapter 6: Discussion 
Summary of Findings 
The national study of Amyotrophic Lateral Sclerosis multidisciplinary utilization 
was designed to investigate the characteristics, differences, and commonalities of patients 
with Amyotrophic Lateral Sclerosis attending multidisciplinary clinics with individuals 
not attending MDCs.  Describing the reasons why individuals seek and attend treatment 
in an ALS MDC assists practitioners providing care to individuals with ALS. The 
primary rationale for conducting this study was to examine the differences in quality of 
life, states of health, and coping skills of patients with ALS attending MDCs compared 
with non attendees, and to describe specific service and treatment differences.  
Qualitative components of the study offer unique data to explore the reasons why ALS 
patients choose to attend or not attend MDCs, the advantages and disadvantages to 
attending, circumstances influencing attendance, and how travel distance impacts medical 
decision making. The study produced expected and significant findings. 
The majority of the participants of this study were from the United States, ten 
individuals self-identified living outside of the United States, and were included in the 
sample. The sample was composed of individuals affiliated with the ALS Association, 
ALS affiliates, and Patientslikeme.com, self- identified as having ALS, and over the age 
of 18.  
The two groups studied were similar by gender and age. Descriptive statistics did 
not find any differences between groups regarding ALS symptom onset, and sporadic and 
familial ALS. A significant difference was found between mean symptom duration 
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between groups. Individuals attending a clinic report longer symptom duration than 
individuals not attending a clinic.   
Hypotheses (H)  
 Three of the four sets of hypotheses in this study were supported with significant 
findings. The four hypotheses were: 1) participants attending a MDC will have better 
coping skills, as measured by Social Problem Solving Inventory-R; 2) participants 
attending a MDC will have higher quality of life as measured by ALSSQOL-R; 3) 
participants attending a MDC will have higher levels of physical functioning, and 4) 
comparison of attendees and non attendees’ overall utilization of treatment and 
professional services will demonstrate that a MDC provides individuals greater access to 
care.   
Hypothesis (H1) theorized that participants attending an ALS MDC would have 
better problem solving skills than individuals who do not attend. Based on a previous 
study, social problem solving skills were shown to affect ALS patients with negative 
emotion, and predict QOL in ALS caregivers (Murphy, Felgoise, Walsh, & Simmons, 
2009). Therefore, this study compared social problem solving skills between attendees 
and non attendees of a MDCs. It was theorized that participants attending MDCs may do 
so to obtain additional services and treatments influencing QOL.    
 H1 was not supported by this study. Problem solving skills did not differ between 
attendees and non attendees. Mean scores on the SPSI-R and subscales were within 
average range compared with the normative sample, and did not differ significantly 
between groups. Thus, both groups were similar and within a normative sample for 
problem solving and coping. Therefore, it does not appear that problem solving and 
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coping skills contribute to ALS patient quality of life or influence medical decision 
making. 
Hypothosis (H2) stated that participants attending ALS MDCs would have overall 
better QOL than non attendees. Previous research compared QOL of ALS patients 
attending and non attending, and found no significant differences in the quality of life 
reports measured by ALSSQOL-R by individuals with ALS attending MDC ALS clinics, 
compared with non attendees (Stephens, Walsh, & Simmons, 2008). 
 Findings indicate that H2 was supported. This study found that individuals 
attending a MDC have better overall QOL than non attendees. This finding is significant 
when compared with previous research in which a difference was not found. This 
supports the fact that clinical expertise, and other resources provided by a MDC may 
serve to modify patient perceptions to the point where physical limitations are seen as 
having less negative impacts. Thus, a MDC may provide certain factors impacting QOL 
in this specific time and population. Establishing a causal relationship is difficult in a 
cross sectional study with an aim to describe the differences between QOL between 
groups without regard for what preceded or precipitated the health status found when the 
participant completed the survey. Thus, a cross sectional study is not able to establish a 
cause and effect relationship between attendees and non attendees, only the existence of 
different health related states. 
Hypothesis  (H3)  indicates that participants attending ALS clinics will have a 
higher level of physical function than non attendees. Traditionally, MDCs provide 
patients greater access to services and treatment practitioners. In a previous study by 
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Penn State Milton S. Hershey Medical Center, disease duration and physical function did 
not differ between the two groups. 
Findings indicate that H3 was supported. Findings reveal that individuals 
attending MDCs perceive QOL as being higher with respect to physical functioning and 
bulbar function than non attendees. However these individuals reported poorer overall 
levels of physical function as measured by the ALSFRS-R, with significantly shorter 
disease duration. It is possible that participants who attend a MDC are evaluated for 
pulmonary function and physical function, and are more aware of disease progression, 
compared with those who are not routinely evaluated by numerous specialist and health 
care providers. Thus, participants who attend a MDC may rate physical function lower as 
a result of increased contact with medical providers. Treatments received at MDCs may 
serve to modify perceptions of health, and serve to modify or alter health beliefs.   
Hypothesis (H4) stated that participant attending MDCs would receive more 
treatments and services for maintaining QOL compared with non attendees. Findings 
indicate that H4 was partially supported. Differences are apparent between the two 
groups. Individuals attending MDCs report higher utilization in 1) antidepressants, 2) 
medication to reduce cramping/spasticity, 3) sleeping medications, and 4) augmentative 
communication devices.  
Non attendees report higher utilization of: 1) medications to reduce saliva 
production, 2) pain medication, 3) treatments for constipation, 4) Percutaneous 
Endoscopic Gastronomy (PEG) or feeding tube, 5) tracheostomy or mechanical 
ventilation, and 6) power wheel chair. Significant amount of services are utilized by 
individuals outside the MDC. These services seem to reflect later stage disease 
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progression: PEG or feeding tube, mechanical ventilations, and power wheel chair. 
Individuals may not be able to access a MDC due to health and other supports, and 
choose not to attend. Qualitative responses support consideration that disease progression 
is a factor in treatment decisions. One participant described attending a MDC for many 
years; regrettably, his health declined, forcing him to change treatment from a MDC to an 
individual practitioner. 
Attendees and non attendees report similar usage of treatment for 1) treatments 
for urinary urgency, 2) NIPPV or BiPAP, and “other”.  
Individuals who do not attend a MDC report higher incidence of receiving no care 
or treatment for ALS. This could be a contributing factor to higher utilization of hospice 
care and alternative medicine. Patients and families may elect not to participate in MDC 
for varied reasons, or choose not to receive any care.  
To be expected, individuals attending MDCs report higher utilization of health 
care professionals: 1) neurologist, 2), nurse, 3) respiratory therapist, 5) physical therapist, 
6) occupational therapist, 7) mental health professional, 8) social worker, 10) dietician, 
and 11) speech therapist. MDCs are developed to provide access to these services, and 
are accomplishing the goal. Additional supports and treatments may have a value and 
influence in quality of life. 
Non attendees of MDCs report higher levels of health care utilization: 1) pastoral 
care chaplain, 2) complementary and alternative medicine, and 3) hospice services. The 
use of pulmonologist and in-home care was similar for both groups.  
Non attendees of MDCs report greater utilization of community or pastoral care, 
and are searching outside of traditional medicine to receive care and support. One 
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particular finding is the rate of utilization for hospice services for non attendees. 
Individuals receiving care from hospice may not be afforded the same opportunity to 
utilize MDCs and may perceive quality of life differently, and thus influence the results. 
Individuals who attend an MDC report poorer levels of physical function; conversely, 
individuals not attending a clinic report higher use of hospice services, a treatment 
utilized with increasing frequency with disease progression. Individuals attending a clinic 
are more clearly aware of their disease progression and are also more knowledgeable 
about ALS. Rating of physical function may be lower based on this factor.  
Individuals who choose to receive care from a solo practitioner may perceive that 
treatments are more effective and efficient in a private setting versus receiving care from 
a MDC setting where multiple providers are trying to see the same patient in a defined 
span of time. Qualitative responses reveal the MDC experience is long and exhausting. 
Respondents did not want to meet with the entire team of specialist in an attempt to 
shorten the day. Non attendees of an MDC may benefit from some of the resources and 
supports of the clinic; therefore, developing a flexible system of care to promote 
communication between MDC and solo practitioners becomes increasingly important in 
providing optimum care for the patient who chooses not to attend a MDC.   
Qualitative findings 
If you go to a multidisciplinary clinic, please tell us why you go 
The specific aim of the study was to examine the characteristics of patients 
affected by ALS who attend MDCs. This was accomplished through a qualitative 
question, asking study participants who attend a MDC to provide information detailing 
reasons for attending. Individuals indicated that they attended because of convenience, 
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travel, and time. This result was expected because previous research found travel and 
convenience a significant factor in attending a clinic. One participant wrote: “everything 
done at one time-doctor, PT, OT, ST. Takes a ½ day but worth it + they are all ALS 
specialist”. Many participants expressed the idea that combining several appointments 
into one day reduced stress and provided increased access to care. Many responses 
referenced the phrase “one stop shopping” when describing the treatment received at a 
MDC.  
A theme emerged regarding the specific care received from a MDC. Respondents 
described the importance of specialist trained in ALS and integrative care, including 
specialized services to deal with loss and frustration. Participants described initial 
interaction with health care professionals who were unfamiliar with ALS, and were 
encouraged to be seen by a team well versed in ALS treatment. In the case of ALS, 
participants responded that many health care professionals outside of a MDC do not feel 
comfortable with patients having ALS or these professionals do not have adequate 
training in caring for patients with ALS. Participants expressed concern with a lack of 
ALS specialist, especially in rural areas, resulting in long travel times to be seen by a 
health care practitioner. Yet they are willing to travel for hours to be seen by a specialist 
trained in ALS. Participants wrote of the ease and satisfaction of one appointment, 
addressing multiple health issues, coordinating care, and reducing stress on family and 
friends.  
Participants were interested in gaining information and knowledge related to 
disease management and evaluation of disease progression. Participants want to have 
information on what to expect in the future, and suggestions to help with daily 
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functioning. Suggestions provided from MDC were perceived as helping with daily 
functioning, resulting in improved independence. Participants were curious and wanted to 
be involved in new clinical trials and research, and perceived the fact that MDC provided 
greater access to these opportunities.  
Participant responses coded in the area of equipment was low. Conversely, as 
found in table 3 and 4, individuals who attend a MDC report higher utilization of 
equipment and services. One possible factor for a low incidence is that respondents used 
the phrase “one stop shopping” and “convenience”, which may broadly be defined as 
services that include equipment.  Additionally, respondents reference the fact that they 
meet with practitioners such as a physical therapist, occupational therapist and speech 
therapist who would be involved in arranging for equipment.  
Advantages or disadvantages from receiving care from a multidisciplinary clinic   
The second aim of the study was to determine the specific, perceived advantages 
or disadvantages from receiving care from an MDC, and explaining psychological, social, 
and medical concerns held by ALS patients. 
The primary advantages identified for attending an MDC were convenience, 
integrated care, and travel time. Respondents consider MDCs to provide greater access to 
multiple providers with greater expertise in treating ALS. The phrase “one stop 
shopping” continues to be a theme in how participants describe experiences at an MDC, 
Respondents also spoke of the advantages of receiving care from multiple providers in 
one day, reducing multiple appointments with various treatment providers. Participants 
expressed a comfort in knowing that ALS specialists were available to provide assistance 
to the patient and family. Patients were willing to travel longer distances to attend a MDC 
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due to the perceived “quality of care and its sophistication”, and coordination of care 
between providers. 
 The prevalence rate of ALS is relatively low, compared with global neurological 
diseases, and disease states. The annual incidence of ALS is 2/100,000 population and the 
prevalence is 6/100,000 (Shoesmith & Strong, 2006).  Generally cases are sporadic and it 
is theorized patients newly diagnosed with ALS are unfamiliar with the disease, do not 
have any friends or family diagnosed with the disease, and are not connected to any 
services. Respondents depend on MDCs to supply resources and information regarding 
disease management as well as information concerning the disease itself. Participants 
described the fact that a MDC provides a central location for information to assist the 
patient in understanding the disease of ALS and also what to expect. Information 
regarding wheel chairs and walkers, and general information “makes it easier to go on.”  
 Participants identified clinical expertise as an advantage of attending a MDC; 
attending provides an opportunity to be seen by a number of health care professionals 
who are specialists in the treatment of ALS. Participants describe early encounters with 
health care professionals who are not trained in ALS, and were not able to provide a 
correct diagnosis or supportive care. Participants recognize the fact that MDC are better 
equipped to provide specific ALS interventions or remedies to alleviate discomfort.  
Participants of MDC interact with other patients, providing mutual support and a 
sense of not being alone. One participant described lunch with fellow patients in a social 
setting, and interaction with others outside of his immediate support group. The support 
of others with a similar illness, and support from staff at the MDC assists individuals and 
alters patients’ perspectives.   
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The primary disadvantage to attending a MDC was travel distance and length of 
day. Participants describe traveling “400 miles in a day” to attend an MDC, and feeling 
exhausted before the first specialist appointment. Waiting to see a specialist, which 
involved extending the length of the day, was seen as a disadvantage; multiple providers 
are trying to see the same patient in a defined period, and this involves wait times 
between specialists. Participants indicated clinics follow a rote protocol; they felt rushed 
through multiple appointments, and were not sure if the total number of specialist seen in 
one day was necessary. Development of a good MDC involves cooperation, 
communication between patient and provider, and assistance for the patient in 
understanding the benefit or reasons for treatment.  
 A third aim of the study asked participants who do not attend a MDC to identify 
reasons why they choose not to attend. The primary reason that participants choose not to 
attend a MDC was travel. Participants indicated that a MDC was located too far from 
home; there was the fatigue of travel, lack of care giver support to transport patient to a 
MDC, exhausting preparation time to travel, and progression of the disease, making 
travel too difficult. The complexity of the disorder, the need for involvement of multiple 
disciplines and recognition of the challenges of providing health care to individuals 
affected by ALS has led to the development of MDC as a means to improve coordination 
and integration of care, and has been shown to improve quality of life. MDCs have long 
been advocated by the National ALS Association as the optimal way to provide care. Yet 
only a few clinics are available within the United States, a primary barrier for care. 
Convincing facilities and organizations to expand funds and support to maintain ongoing 
programs or to develop new MDCs is particularly challenging. New and innovative ways 
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to reduce travel barriers are needed. Dorsey and colleagues (2010) found that 
telemedicine increases access to specialty care and improves quality of life for patients 
with Parkinson’s disease who reside in remote locations greater than 130 miles from an 
academic movement disorders clinic. Features of telemedicine include specialized 
referral services, remote patient monitoring, patient consultation, and medical and health 
education. Utilization of new technology such as telemedicine may be an opportunity to 
expand services to and coordination with individuals who are not able to access a MDC.  
Participants explained that were uninformed and also they were not referred; these 
constitute two reasons why that they had not attended a MDC. One participant wrote: “I 
have never had the opportunity, nor even heard of that option.” This illustrates the 
continued need for education and information to individuals diagnosed with ALS, and 
also for coordination of services.  
 The fourth aim of the study was to examine the characteristics of individuals who 
do not attend a MDC, and what circumstances would influence their decision making to 
attend. Participants indicated that the primary reason for electing to be seen outside of a 
MDC was distance. If the clinic was available locally, participants would go. Financial 
costs of attending a clinic were described as factors in determining treatment decisions. 
Participants indicated a lack of understanding or a lack of awareness about the function of 
a MDC; they would consider a MDC if they had additional information, or if their health 
declined. Overall, participants recognize the benefits of a MDC and would consider this 
treatment option. 
The fifth aim of the study was to determine how travel distance to a MDC 
influences treatment decisions. Participants (N=144, 62.9%) indicated that distance did 
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not influence decision making, and would make the trip regardless of time and travel, 
perceiving that the MDC provides greater care and expertise. Travel to a MDC was a 
common concern to participants of the study. Respondents planned, however, to continue 
attending a MDC regardless of the travel for the perceived benefits the MDC provided: 1) 
specialist, 2) integrative care, 3) information and knowledge. 
Participants who indicated that travel influenced medical decisions described four 
primary barriers: 1) coordination, 2) expense, 3) physical discomfort, and 4) stage of the 
disease process and fatigue. Individuals not attending a MDC would consider care from a 
MDC if it were closer; if participants better understood the function of a clinic, and if 
health declined. Only (N=6), a small percentage, would not consider attending a MDC. 
Overall, participants explained that receiving care at a MDC had improved quality of life. 
Significance of the findings     
In this study, patients with ALS attending a multidisciplinary clinic differ from 
those who do not attend. First, participants who attend a MDC report a shorter duration of 
the disease compared with those who do not attend. Second, participants attending a 
MDC identify poorer overall levels of physical function. It is theorized that increased 
monitoring from the MDC could influence patients’ perceptions regarding physical 
functioning. Third, participants attending a MDC report higher overall quality of life, and 
higher perceived QOL in relation to physical and bulbar function. These finding are 
significantly different from a previous study conducted by Penn State Milton S. Hershey 
Medical Center; disease duration and physical function did not differ between groups, 
and there were no significant differences in the QOL reports by individuals with ALS 
who attend a MDC compared with those individuals with ALS who do not attend ALS 
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clinics. Supports, specialists trained in ALS care, and integrative care may serve as 
factors changing patient perspectives, and altering quality of life. Participants attending 
MDCs report receiving additional treatments and higher utilization of professional 
services than non-attendees. 
The literature is void regarding qualitative factors connecting the reasons why 
individuals choose to attend a MDC, compared with receiving traditional practitioner-
driven care. This study categorized reasons why people attend a clinic, the advantages 
and disadvantages of a MDC, the reasons why people do not attend, the circumstances 
influencing a decision to attend, and how travel impacts medical decision making. To be 
expected, travel and access were primary influences; however, respondents are willing to 
travel long distances to be seen at a clinic, illustrating the fact that participants’ perceived 
benefits of MDC supersede travel time. Individuals searching for information, specialized 
treatment, and support perceive the fact that the MDC is a “one stop shop”, where 
identified medical needs are met, thus increasing quality of life.  Those individuals 
attending a MDC indicated that the MDC approach consolidates many appointments into 
one day, reducing overall travel, time, and expense. Participants who reported travel 
distance was a disadvantage stated that this was the case, specifically as disease 
progression led to decreased mobility and need for medical technology. Primary 
circumstances influencing ALS attendance were travel and distance from home. 
Interestingly, (N=9) participants were not aware of the function of a MDC, illustrating a 
need to continue advertising the benefits, function and availability of ALS clinics. 
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Relevance of the study to the theory and practice of psychology 
Individuals are increasingly aware and accepting of the benefits of psychological 
interventions and services for emotional, physical, and psychological stress. Kurt and 
colleagues (2007) examined depression and anxiety in individuals with ALS and found 
the primary focus of palliative therapy in ALS is in coping with physical symptoms, but 
the psychological aspects of the disease are neglected. Patients and caregivers could 
benefit from greater access to psychological services delivered in a MDC. Two 
participant responses made recommendations for MDC related to psychological needs; 
one response identified opportunities to expand services by including access to Primary 
Care Physicians (PCP). MDCs do provide psychological services and holistic care. 
Patients and care givers may not be aware of these and of other services and focus on 
primarily receiving care from medical professionals. Responses regarding psychological 
and PCP services were found in the qualitative section, soliciting participants to describe 
advantages and disadvantages of attending a MDC. Participants wrote:  
“Think psychiatric is another need which is not really addressed there”  
 
“The ALS MDC is very focused, synchronized and provides superb 
support. There are no disadvantages. This is how it should be. The only 
way they could make it better is to include a nutritionist and psychologist 
as well.”  
 
“A central place for all medical needs is good. Unfortunately, they don’t 
provide primary care.” 
 
Implications of research findings related to diversity 
 Practitioners are increasingly faced with providing care in a multicultural society. 
Language barriers and health literacy complicate health care delivery. MDC need to be 
increasingly aware of communication styles when delivering information or assessing 
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disease progression with individuals from different backgrounds. Safe and quality health 
care to individuals requires MDCs and practitioners to understand how patients’ 
socioeconomic backgrounds affect health beliefs and behaviors. MDCs need to consider 
ethnic, cultural, and economic backgrounds of patients. This study found that non 
attendees utilized pastoral care or chaplains at higher percentages (Attenders N=34, 14.2; 
Non Attenders N=17, 19.1) than attendees.  Individual religious beliefs may be one factor 
influencing how care is received and perceived. Understanding cultural competency and 
health care beliefs, including interaction with unfamiliar medical systems of care may 
increase access to medical care and affect quality of life.   
Implications of research findings as related to advocacy 
Current treatments cannot stop or reverse ALS, and the current focus of care is on 
maintaining or improving QOL. Patient Centered Medical Home (PCMH) is an approach 
to providing comprehensive care and maintaining quality of life. The American Academy 
of Pediatrics developed the medical home model for delivering primary care that is 
accessible, continuous, comprehensive, family-centered, compassionate, and culturally 
effective to coordinate care for children with multiple and special health care needs 
(Stange, Miller, Nutting, Crabtreee, Stwart, & Jaen, 2010; Peek, 2010).  PCMH works in 
collaboration with patients and families to facilitate partnerships between physicians, 
specialists, and community resources to optimize treatment and coordination of care. 
PCMH provides services to equip patients with an understanding of specialty care, 
provides educational services, out of home care family support, and other links to private 
and public services important for the overall health of a person. PCMH de-fragments 
health care, and provides accessibility at the times of patients’ greatest need. Advocating 
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for this model brings providers and patients together to plan care, and create strategies to 
reduce barriers.  
Limitations 
Limitations of this study include lack of relevant demographic information 
including: marital status, social supports, other care giver supports, and socio economic 
status. Certain factors may contribute to overall QOL, and provide a catalyst for a person 
to choose attendance at a MDC. Supports relevant to specific demographic information 
could assist the individual with transportation, encouragement, and be a significant factor 
in contributing to quality of life to the extent of altering patients’ perspectives and 
expectations regarding physical limitations. Conversely, individuals devoid of resources 
may find it difficult to attend a MDC.  
 External validity is affected by selection bias. Individuals routinely evaluated at 
MDCs have social supports, and may be less vulnerable to depression and psychological 
distress. Patients with severe depression, with a lack of social supports, and with 
difficulty coping with ALS are less likely to volunteer for research. Study volunteers may 
not be typical of average ALS patients. The study participants will need access to a 
computer, skills in utilizing a computer, and depending on the progression of the disease 
adaptive devices or social supports to complete the survey. Possession of a home 
computer may be associated with greater financial stability, and higher socioeconomic 
class.  
 Participants connected to the ALS community were to be informed of the study, 
and notification of the study may not have reached ALS patients residing in rural areas 
MULTIDISCIPLINARY CLINIC UTILIZATION  69 
         
 
not connected to ALS supports, or individuals not affiliated with the ALS community. 
Individuals with low QOL may not be interested in responding to the survey.  
Differentiation of attendees and non attendees was by self-selection in question 
one. All survey participants had full access to the qualitative questions and were not 
directed to respond to certain question based on attending status. It is possible that 
participants could have responded to all questions regardless of attendance status. A 
number of participants responded with N/A, potentially indicating that a participant read 
the question, realized it was not applicable based on attendance status, and did not 
continue. However, a participant could answer the question by mistake, influencing the 
results. Reviewing the first qualitative question one participant wrote “I have never 
attended.” The risk was reduced by having multiple coders review the responses and 
agreeing on which response to include in the analysis. Future survey design should 
include limited access to survey questions for each group, decreasing the opportunity to 
respond accidently to a question. 
Suggestions for Future Work 
 This study was an attempt to gather information about the reasons why 
individuals attend or do not attend a MDC, circumstances in which a person would 
consider attending, and how travel determines treatment decisions. The study examined 
differences in QOL, physical functioning, and coping skills to further understand how 
individuals make decisions regarding their ALS and how a ALS MDC improves quality 
of life.   
Qualitative analysis revealed convenience, travel, time, specialists, and integrative 
care were primary reasons for individuals’ attendance at a MDC; conversely, individuals 
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did not attend a clinic due to travel distance, long exhausting days, and physical 
discomfort. 
Future considerations would be an evaluation of barriers found in accessing a 
MDC, travel distance, and physical environment. One participant responded to the 
advantages and disadvantages of a MDC by describing the difficulty traveling and the 
long exhausting day of appointments at the clinic. Especially noted were the wait times 
between specialist appointments, time with “nothing to do”, and “lack of food and drink.” 
Future directions could be an evaluation of the physical environment and ways to 
improve perceptions of attendees and non attendees of a MDC.  A second participant 
response noted a negative experience, influencing his decision to attend.  
 “The advantage is getting input from many disciplines in ‘one stop’. Two 
disadvantages are that the day is exhausting and I don’t necessarily need to 
see all of the “specialists” in the clinic (but I have to anyway). 
Additionally, the clinic is clinic is 55 miles from my home and I have to 
arrive by 8:15 A.M. meaning my day starts way too early. I’m tired before 
I get there. I hate the waiting in between specialists with nothing to do, 
nothing to eat or drink. The whole ordeal sometimes takes as long as 7 
hours.” 
 
Future research considerations could include qualitative analysis of the impact of 
psychological interventions found at a MDC and ALS patients and care givers’ 
perceptions of treatment. It could also include an evaluation of those aspects that were 
found to be valuable and also those that were not useful. This could provide practitioners 
with a better understanding of how ALS patients and care givers would prefer to receive 
psychological interventions from the beginning diagnosis to later stage of the disease 
progression when speech is affected or lost, and mobility to attend psychological services 
outside of the home is difficult. 
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Summary and Conclusions  
 Current treatments cannot stop or reverse ALS. The current focus of care is on 
maintaining or improving QOL. Individuals attending an ALS clinic receive additional 
resources, medical treatments, and support. Salient features of how a MDC impacts the 
overall QOL was examined in this study; further exploratory research is beginning to 
reveal the reasons why individuals choose to attend an ALS clinic, the perceived benefits 
of this delivery of care, and any perceived barriers. The qualitative approach provides the 
researcher the opportunity to better understand the nature or meaning of a particular 
human experience from a national sample of individuals.  
One of the significant advantages of a national web based survey method is that 
the collection of data is representative of a larger population. The findings and results 
from this study can be generalized to reveal wider social patterns and trends, and 
implications and generalizations can be made from the data that represent unique 
perspectives and health care beliefs of individuals across the United States. In a broader 
context, results of the reasons why individuals attend a MDC are relevant to other 
disciplines in the medical field that utilize the MDC approach to care; these include 
oncology and heart failure. Understanding the reasons why individuals attend a MDC or 
choose not to attend will provide exploratory information to the National ALS 
Association and medical practitioners in developing service provisions exclusively to 
provide care for ALS patients; understanding these reasons also offers a unique 
perspective of potential barriers for individuals who receive care from traditional 
practitioner care. Previous research, as well as this study identified travel and distance to 
a clinic as significant barriers to accessing care. Specific interventions might target travel 
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and accessibility. Future directions may focus on opportunities to decrease barriers faced 
by individuals who do not attend a MDC. 
This study is part of a larger program of research designed to identify and address 
the psychosocial needs of individuals with ALS and their families. The study sought to 
discover the reasons why individuals with ALS access MDC versus receiving traditional 
practitioner driven care; it also sought to measure objectively  the coping skills, quality of 
life, and physical function between groups. The overarching goal was to describe the 
nature and meaning of these human experiences, and to develop new knowledge from the 
perspective of individuals with ALS.  
This study delves beyond the obvious to gain subjective understanding into 
identifying categories or themes directly related to Quality Of Life perceptions of ALS 
patients. Attending a Multi-Disciplinary Clinic would improve the QOL for individuals 
with severe disabilities and with prospects of a debilitating disease. A particular finding is 
that patients attending a MDC ALS clinic perceive QOL as being higher with respect to 
physical function and bulbar function; however, these patients have poorer overall levels 
of physical function as measured by the ALSFRS-R. It cannot be assumed that QOL 
decreases as the number of symptoms or degree of disability increases, inferring that 
perceived satisfaction with life depends on subjective conditions versus objective 
measures. A participant responding to reasons why he or she attends a MDC wrote: 
“At this point I feel it will give me the best chance to deal with the 
challenges I expect to have in the future. It will allow me to monitor how 
the disease is progressing using one source rather than putting everything 
together on my own.” 
 
Multidisciplinary Clinics provide enhanced care coordination, increased 
accessibility to health care professionals skilled in treating Amyotrophic Lateral 
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Sclerosis, and improvements in symptom control for patients with ALS. MDCs offer a 
comprehensive environment for treatment of ALS and are appropriate with onset of 
symptoms to obtain accurate diagnosis in an efficient manner.  
The Patient-Centered Medical Home supports the MDC model by organizing care 
around patients, by working in teams, and by coordinating and tracking care over time. 
The main concern for this model is the reduction in need for primary care physicians; yet, 
this may alleviate the shortage of PCPs. The structure of the Patient-Centered Medical 
Home facilitates partnerships between patients, physicians, and family members.   
Lack of funding is the predominant reason for the small numbers of MDC 
locations. Access to MDCs is an issue because of mobility, loss of functionality, distance 
to MDC sites, and level of needed caregiver support: Use of telemedicine should be 
explored to improve patient confidence in the ability to manage care. Supports and 
resources provided for ALS patients in MDCs serve to alter the overall patient 
perspective of quality of life.  
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Appendix A: Questionnaire 
Introduction: 
A National Study of ALS Multidisciplinary Clinic Use 
1. A National Study of ALS Multidisciplinary Clinic Use 
Researchers under the direction of Dr. Zachary Simmons at the Penn State University 
College of Medicine are interested in learning about the quality of life, problem solving, 
and use of clinical services of persons with ALS (PALS) across the United States. This 
study will take approximately 60 minutes of your time to complete a set of questions abut 
your physical health state, your quality of life, and information about where you live and 
what type of care you receive for your ALS. The information that you provide in this 
survey is confidential and will be shared only with the research team. This survey is 
labeled with a code number and not with your name or other identifying information. If 
you should have any questions or concerns about this study, please contact the study 
coordinator, Beth Stephens, at (717) 531-003, 283395 or hstephens1@psu.edu. 
 
Risks and Discomforts: 
There is no physical discomfort, and there are no physical risks associated with this 
study. You may experience emotional discomfort and become upset due to thinking about 
how all these factors impact on your life. You may experience fatigue (tiredness), so 
please work at your own pace. 
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Only one questionnaire response will be accepted per computer. 
If you have participated in a Quality of Life study in the past (i.e., in a clinic setting), you 
are still eligible to participate in this study. 
2. Demographics 
Age 
___What is your age in years? 
Gender 
___Male 
___Female 
Site of ALS Symptom Onset 
When did you first notice symptoms of ALS? If you do not know the exact date, please 
use “01” for month or day 
MM/DD/YYYY 
Site of ALS Symptom Onset 
___Limb 
___Bulbar 
___Breathing 
ALS Diagnosis 
When were you diagnosed with ALS? If you do not know the exact date, please use “01” 
for month or day 
MM/DD/YYYY 
Do you have other family members with ALS? 
___Yes 
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___No 
Tell us where you live 
State: 
Zip / postal code: 
Country: 
3. Multidisciplinary Clinic Use 
Some people with ALS attend a multidisciplinary clinic. We define a multidisciplinary 
clinic as a team of health care providers including: neurology, physical therapist, 
occupational therapist, nutritionist, speech therapist, mental heath clinician, social 
worker, nurse, and others. Other ALS patients do not received medical treatments from a 
multidisciplinary clinic; they go to neurologists, other doctors and health care 
practitioners. 
How often have you attended a multidisciplinary clinic (MDC)? 
___ Never, and I have no plans to attend a MDC 
___ Never, but I have a scheduled appointment or plan to attend in the upcoming future 
___ One time for a single diagnostic visit, but I have no plan to attend again 
___ One time, and I have a schedule appointment or plan to attend in the upcoming future 
___ More than 1 time, and plan to continue my treatment at a MDC 
___ More than 1 time, and I do not plan to continue my treatment at a MDC 
If you do go to a multidisciplinary clinic, please tell us why you go. Please give us as 
much information and detail as you can. 
________________________________________________________________________
________________________________________________________________________
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________________________________________________________________________
________________________________________________________________________ 
Please tell us about any advantages or disadvantages from receiving care from a 
Multidisciplinary Clinic. Please give as much detail and information as you can. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
If you do not go to a Multidisciplinary Clinic please tell us why. Please give us as much 
information as you can. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
If you do not attend a multidisciplinary clinic, under what circumstances might you 
attend an ALS clinic? Please give us as much information as you can. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
If you attend a multidisciplinary clinic, who influenced your decision to attend a 
multidisciplinary clinic? 
___ Spouse or other family member 
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___ Physician 
___ Another ALS Patient 
___ALS Association, Muscular Dystrophy Association, or other disease-based group 
___No one. I made the decision on my own 
___ Other 
Other (please specify) ____________________________ 
Who first told you about a multidisciplinary clinic? 
___ Neurologist 
___ Primary Care Physician 
___ Internist 
___ Nurse 
___ALS Association, Muscular Dystrophy Association, or other disease-based group 
___ Other: please specify ___________________ 
Distance of ALS Clinic 
4. Treatments and Services for ALS 
How does travel distance to a multidisciplinary clinic or other health care professional 
influence your treatment decisions? Please give as much information as you can. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
What treatments do you use for your ALS? 
___ Riluzole (Rilutek) 
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___ Antidepressants 
___ Medications to reduce saliva production 
___ Medications to reduce cramping/spasticity 
___ Pain medications 
___ Sleeping medications 
___ Treatments for constipation 
___ Treatments for urinary urgency 
___ Percutaneous endoscopic gastronomy (PEG) or feeding tube 
___ NIPPV or BiPAP 
___ Tracheostomy or Mechanical Ventilation 
___ Augmentive Communication device 
___ Power Wheel chair 
___ Experimental medications 
___ No treatment 
___ Complementary and Alternative Medicine (includes supplements, massage, holistic           
medicine, chiropractice care, acupuncture, etc) 
___ Other (please specify)_________________________ 
Do you use or have you been referred to any of these health care providers as part of your 
care for ALS? Check all that apply 
___ Neurologist 
___ Nurse 
___ Respiratory Therapist 
___ Pulmonologist 
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___ Physical Therapist 
___ Occupational Therapist 
___ Mental Health Professional 
___ Social Worker 
___ Pastoral Care or Chaplain 
___ Dietician 
___Speech Therapist 
___ Complimentary and alternative medicine professional (chiropractors, naturopathic 
doctors, acupuncturists, etc). 
___ In Home Care 
___ Hospice Services 
 
Demographic Questions 
 Today’s Date 
 Age (in years) 
 Date of onset of ALS symptoms (month/year) 
 Date of Diagnosis (month/year) 
 Gender (male/female/prefer not to answer) 
 Site of ALS symptoms (limb, bulbar, breathing) 
 Do you have other family members with ALS (yes/no) 
 Distance from nearest MDC to home in miles 
 Zip code 
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Appendix: B Study Announcement 
 
Persons with Amyotrophic Lateral Sclerosis (ALS) 
Wanted for a Research Study 
 
Researchers at Penn State College of Medicine are seeking participants for a research 
study on why individuals access a multidisciplinary clinic versus receiving traditional 
practitioner care, Quality of Life (QOL), and social problem solving skills of persons 
with ALS.  The purpose of the study is to better understand the QOL, and problem 
solving skills of patients with ALS who receive different forms of care for the disease. 
Participants will complete a questionnaire (online or with a paper and pencil version) that 
asks questions about physical health status, quality of life, social problem solving skills, 
and use of medical services for care of ALS.  Survey responses are confidential.  
All persons 18 years of age or older, who have been diagnosed with the disease 
Amyotrophic Lateral Sclerosis are eligible to participate in this study.  
 
To access the online questionnaire, go to our ALS Clinic website: 
http://www.alsphiladelphia.org/pennstatehershey 
 
For more information or to request a paper copy of the questionnaire, call the study 
coordinator, Beth Stephens, at 717-531-0003, extension 283395, or by email at 
hstephens1@psu.edu  
 
Study Director: Zachary Simmons, MD, Department of Neurology, Penn State College of 
Medicine. 
 
 ‘This research study has been approved by the Institutional Review Board, under federal 
regulations, at Penn State College of Medicine, Penn State Hershey Medical Center.’ 
Appendix: C Hershey Medical Center IRB Abstract 
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Req....JfCI'WiiteroiCoosenloiociOrig. ti),O'I.OS; Rer. 1011712005) 
IRB Protocol No.: 
~STITUTION AL REVEW BOARD 
PENN STATE COLLEGE OF MEDICilE 
Penn State MiHon S. Hershey Medical Center 
REQUEST FOR WAIVER OR ALTERATION OF CONSENT 
Protocol Title: A National study of Amyotrophic Lateral Sclerosis Multidisciplinary Clinic Util~alio n. 
Principal Investigator: ~achary Simmons 
According to the federal regulations, an IRB may waive the requirements to obtain informed consent or 
approve a consent procedure which does not include, or which alters, some or all of the elements of 
informed consent provided the IRB finds and documents that: (1) The research involves no more than 
minimal risk to the subjects; (2) The waiver or aHeration will not adverse~ affect the rights and weHare of 
the subjects; (3) The research could not practicab~ be carried out without the waiver or alteration; amd (4) 
Whenever appropriate, the subjects will be provided with additional pertinent information after participation. 
To request a waiver or aHeration of the requirement to seek informed consent of subjects, complete tthe 
following 
1. Indicate which of the following applies (Selecl! Q.!J!): 
D a. Informed consent will not be obtained. 
D b. A co nsent procedure will be used which does not include, or which a Hers, some or all of the 
elements of informed consent. 
Explain which elements are not included or which elements are altered and why this is 
necessary: 
2. Describe how the research meets .ill!_ of the following four cond~ions: 
a. The proposed research involves no more tham minimal risk to the subjects because: 
]Wn online questionnaire that asks a national sample of patients with ALS about their medical service use, qualil): 
b. The waiver or aHeration will not adverse~ affect the rights and weffare of the subjects because: 
participants can can chose not to complete the online survey or can stop participation at any time 
c. The proposed research could not practicably be carried out without the waiver or aHeration 
because: 
it is an online survey available on our ALS Clinic webs~e. informed consent is not practical for this study. 
d. Whenever appropriate, the subjects will be prov ided with additional pertinent information after 
participation (Indicate why information will noti be provided .2! explain why, how, and when 
information will be provided): 
~unary of the results of the study Will be posted on our ALS Clinic webSit 
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IRB. No. ____ 
Date 
Office Use Only:  ________ 
Institutional Review Board 
Penn State College of Medicine 
Penn STATE MILTON S. Hershey Medical Center 
 
Protocol Summary Abstract 
 
Title: A national study of Amyotrophic Lateral Sclerosis Multidisciplinary Clinic Utilization 
Principal Investigator:  Zachary Simmons, MD        Dept./Div:   Neurology 
 
 1.   Rationale:  The study is designed to discover why individuals with ALS access multidisciplinary clinics 
versus receiving traditional practitioner driven care, and to discuss the differences in quality of life, 
functional status, and coping skills for these two distinct ALS populations. The research project is 
guided by the following question: For what reasons did you decide to seek treatment and services at 
an ALS multidisciplinary clinic? The investigation is part of a larger program of research designed to 
identify and address the psychosocial needs of persons with ALS and their families. Hypothesizing that 
the findings will show a higher quality of life, coping skills, and significant differences in states of health 
of individuals with ALS attending MDC compared to individuals receiving traditional care.  
 
2.   Key Objectives: To examine the characteristics of persons affected by ALS who access a MDC clinic 
versus receiving traditional practitioner driven care. Collect Quality of Life, Functional Rating, and 
coping skills data on a national sample of patients with ALS. 
 
 3.   Study Population: National sample of patients diagnosed with ALS and who are registered with the ALS 
Association. 
 
 4.   Major Inclusion & Exclusion Criteria: Diagnosis of ALS   
 
 5.   Method of Identification of Subjects/Samples/Medical Records: Participants will be notified of the study 
by the ALS Association through the distribution of flyers, letters, and postings on newsletters and 
websites.  Dr. Simmons will notify his own patient population with a letter.  No medical records will be 
used for this study. The investigators will not have access to the registry of patients with the ALS.   
 
 6.   Consent Process and Documentation: The investigators request a waiver of informed consent.  
Completion of the anonymous survey will imply consent for participation in the research.    
 
 7.   Allocation to Groups: Data will be analyzed by groups: 1) ALS patients receiving multidisciplinary care; 
2) ALS patients receiving other forms of care.      
 
 8.   Summary of Procedures: Participants will complete an anonymous survey on the internet that asks 
questions about why they do or do not attend an ALS Multidisciplinary Clinic, QOL, functional status, 
coping skills, and type of care and treatments used for ALS.  Alternatively, participants can request a 
paper copy of the questionnaire and postage paid and addressed envelope to return the survey.  No 
coding system will be used to identify survey responses. 
 
 9.   Major Risks & Discomforts: Possible emotional discomfort from thinking about one’s quality of life with 
ALS. A statement at the beginning of the survey will address this potential discomfort. 
        
10.  Potential Benefits: No benefits to the participant.  The study will provide us with a greater understanding 
of why ALS patients attend or do not attend a Multidisciplinary Clinic, QOL, functional status, and 
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coping skills, from a national population of ALS patients, and will aid in the understanding of the 
association of QOL and coping skills with use of multidisciplinary care.  
 
11.  Privacy and Confidentiality: Response to the survey is anonymous.  There is no code that links survey 
responses to individual participants. Data will be stored in a password protected and secure server in 
Neurology. 
           
12.  Qualifications and Research Experience of Principle Investigator:  Zachary Simmons, MD has directed 
the ALS clinic at Penn State Hershey Medical Center since its inception in 1995, and has a long-
standing research interest in understanding QOL in patients with ALS.  Dr. Simmons has presented his 
research findings at national conferences and academic meetings and has authored numerous papers 
on QOL in ALS.  
 
13.  Study Site Location(s) The internet survey will be hosted by Survey Monkey ®.  The survey will be 
posted on the website of the ALS Association and the website of the Penn State Hershey ALS Clinic.   
 
14.  References: Traynor, B. J., Alexander, M. Corr, B. Frost, E., & Hardiman, O. (2003). Effect of a 
multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: A population based study, 
1996-2000. Journal of Neurology Neurosurgery and Psychiatry, 74, 1258-1261. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
